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ABSTRACT
The Blood-Brain barrier (BBB) is a specialized structure which lim-
its molecular passage between the vasculature and the brain. This
greatly inhibits treatment of disorders of the brain and CNS. Ul-
trasound in combination with circulating microbubbles has been
shown to locally, non-invasively and reversibly disrupt the BBB to
allow delivery of pharmacological agents to the brain. Focused ul-
trasound (FUS) disruption of the BBB is an increasingly researched
area which is close to its first clinical use. However, sources of
variability in treatments exist and there is a need for a real-time
monitoring and control technique to improve treatment safety. This
thesis investigates and attempts to minimize sources of uncertainty
through novel techniques. Standing waves in pre-clinical models
are investigated and a novel burst sequence is presented which
eliminates standing waves in the skull cavity during therapeutic
bursts. The parameter space over which the novel burst sequence
is effective is investigated. The effect of the variability in rodent
skull thickness on the insertion loss and resulting in situ pressures
is examined. Relationships are established to better predict in situ
pressures in rat models at clinically relevant frequencies. A wide-
band hydrophone and a control algorithm are developed to monitor
microbubble acoustic emissions during FUS BBB disruption and to
use them to actively control treatment pressures in real-time. Fi-
nally, an initial investigation of a clinical scale system is presented
which examines the feasibility of translating the treatment moni-
toring and control to a clinically relevant platform. Results of these
studies are presented and their implications are discussed.
PACS Classification: 43.35.Wa, 43.80.Sh
National Library of Medicine Classification: QT 34, WB 515, WL 200,
WL 300
Medical Subject Headings: Ultrasonics; Ultrasonic Therapy; Blood-Brain
Barrier; Microbubbles; Drug Delivery Systems; Brain; Algorithms; Feed-
back; Acoustics; Skull; Models, Animal
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BCNU 1,3-bis(2-chloroethyl)-1-nitrosourea
BTB Blood-Tumor barrier
CE contrast enhanced
CW continuous wave
DCE-MRI dynamic contrast enhanced MRI
EB Evans Blue
ETL echo train length
FOV field of view
FSE fast spin echo
FUS focused ultrasound
GPIB general purpose interface bus
MB microbubble
MGE multi gradient echo
MRI magnetic resonance imaging
PCD passive cavitation detector
PL pulse length
PRF pulse repetition frequency
PVDF polyvinylidene fluoride
PZT lead zirconate titanate
RARE rapid acquisition with refocused echoes
ROI region of interest
SB short burst
SNR signal to noise ratio
SPIO superparamagnetic iron oxide
SWI susceptibility weighted imaging
T1w T1 weighted
T2w T2 weighted
T2*w T2* weighted
TB Trypan Blue
TE echo time
TJ tight junction
TR repetition time
UCA ultrasound contrast agent
US ultrasound
SYMBOLS
a radius
f0 fundamental frequency
J1 first-order Bessel function of the first kind
λ wavelength
T1 T1 relaxation time
T2 T2 relaxation time
T2* T2* relaxation time
1 Introduction
Focused ultrasound (FUS) disruption of the Blood-Brain barrier
(BBB) is an emerging technique for targeted drug delivery to the
brain. Its main advantages are its non-invasive and reversible na-
ture. The technique has the ability to facilitate the passage of thera-
peutics from the vasculature to the brain tissue, which is normally
impeded by the presence of the BBB. FUS BBB disruption (BBBD)
has been highly researched in the past ten years, and the research
suggests that clinical investigations are not far off. However, there
remain many important aspects to be investigated to ensure both
treatment safety and efficacy.
The objectives of the work in this thesis were to investigate the
sources of uncertainty inherent to transcranial BBBD and to im-
plement improved techniques to minimize them. The overarching
theme of the studies was improvement in treatment safety and ef-
ficacy. While many elements of FUS induced BBBD could be in-
vestigated, in this work emphasis was placed on three factors: the
impact of standing waves in the skull cavity, variations in skull bone
thickness in animal models, and the importance of microbubble be-
havior. The specific aims of the work were:
· To develop appropriate tools for investigating microbubble
behavior during BBBD
· To investigate the influence of standing waves on BBBD and
to develop a technique for BBBD in the absence of standing
waves
· To investigate the variations in skull bone thickness in rodent
models and their effect on ultrasound transmission, and to
determine if a relationship can be established between animal
mass and ultrasound transmission in order to improve in situ
pressure estimates
O’Reilly M.A.: Methods for FUS-Induced BBB Disruption
· To determine if BBBD can be safely controlled using real-time
feedback control based on microbubble emissions
These aims were addressed in Publications I-V. In Publication I
an MRI-compatible, wideband piezopolymer hydrophone was de-
veloped for the specific purpose of monitoring microbubble acous-
tic emissions during transcranial FUS. In Publication II, standing
waves were investigated in ex vivo rat skull cavities and a modified
pulse was used to eliminate them. The modified pulse was then
implemented to disrupt the BBB in the absence of standing waves.
Publication III further examined BBBD in the absence of standing
waves by investigating the robustness of the modified pulse and
the influence of different acoustic and injection parameters on treat-
ment safety and efficacy. In Publication IV ultrasound transmission
through rat skull was investigated as a function of animal mass in
order to determine if in situ pressure estimates could be improved
by considering animal size. Finally, in Publication V a control al-
gorithm was implemented to modulate treatment pressures dur-
ing BBBD based on microbubble acoustic emissions. Among other
things, Publication V investigated if the need for exact in situ pres-
sures in BBBD could be removed by instead achieving a certain
microbubble behavior.
Chapters 2 and 3 of this thesis provide an overview of ultra-
sound use in the brain, including diagnostic and therapeutic ultra-
sound, as well as a review of Blood-Brain barrier disruption and
the relevant literature. In Chapter 4 the methods used in studies
I-V are described, followed by a review on the results of each pub-
lication in Chapter 5. In Chapter 6 unpublished work relating to
the clinical translation of Publications I and V is described. Finally,
the significance of the work presented in the thesis as a whole is
discussed (Chapter 7). The original publications can be found in
the appendix.
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2 Ultrasound and the Brain
2.1 BRAIN CANCER AND CNS DISORDERS
According to the 2008 World Cancer Report, there are approxi-
mately 175 000 cases of primary central nervous system tumors
each year, worldwide [23]. Glioblastomas are the most common
type of brain tumor, for which the three-year survival rate is less
than 3% due to their resistance to radiation and chemotherapy [23].
In addition to primary tumors, studies suggest brain metastases
may develop in up to 19% of lung cancer patients [18] and any-
where from 5% [18] to 30% of breast cancer patients [231]. For
treatment, surgical approaches are highly invasive and always in-
volve cutting through healthy tissue. In addition, many patients do
not meet criteria for surgical interventions. Radiation therapy or
brachytherapy can be used as treatments, but the use of ionizing
radiation can damage the healthy tissues [30, 57, 121]. Chemothera-
peutic approaches for treatment of brain cancers face similar limita-
tions to drug therapy for non-cancerous brain and CNS disorders.
The number of individuals who suffer from other CNS disor-
ders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy,
schizophrenia and stroke, to name a few, is high. For example,
in 2010, Alzheimer’s Disease International (ADI) reported that ap-
proximately 4.7% of the global population over 60 years of age
suffers from Alzheimer’s or dementia [253]. In some regions of
Europe and the Americas, this affects closer to 7% of the over-60
population. Brain disorders are very difficult to treat with pharma-
ceuticals as the majority of known therapeutic agents (>98%) are
restricted from crossing from the vasculature into the brain tissue
by the blood-brain barrier (BBB) [171], which is described in detail
in Chapter 3. The prevalence of brain cancers and CNS disorders
and the difficulties associated with treating them highlight the need
for the continued development of novel treatment approaches.
Ultrasound (US) has several advantages which make it well
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suited for diagnostics and therapy in the brain. First, it is non-
ionizing and can be used non-invasively. As a diagnostic modality,
ultrasound equipment is less expensive than its CT or MRI coun-
terparts and has the advantage of being relatively portable. These
features make it much more accessible, although its use in the brain
is very limited. For therapeutic purposes, ultrasound energy can be
focused deep into the body in order to produce a range of thera-
peutic effects, which are described in the following sections.
2.2 ULTRASOUND AND THE SKULL BONE
The use of ultrasound in the brain presents several unique chal-
lenges. The skull bone (Fig. 2.1) is the biggest impediment to the
use of ultrasound in the brain. The skull is comprised of an outer
layer of dense cortical bone which encapsulates a porous trabec-
ular bone center. Skull bone is heterogeneous, and has irregular
geometry.
The longitudinal speed of sound in the skull bone varies with
location and frequency, but is on average approximately 2900 m/s
[70, 180], twice that of water. Both speed of sound and attenuation
increase with increasing density of the trabecular bone [170]. As a
result, sound passing through the skull undergoes inhomogeneous
phase shifts, resulting in a defocusing of the beam. Refraction ef-
fects arising from non-normal incidence of the ultrasound on the
skull further distort the beam profile.
In addition to dephasing of the beam, the insertion loss of the
skull is very high. This is due to a combination of factors. First, the
acoustic impedance of bone differs significantly from both water
and soft tissue, resulting in high reflective losses at the tissue-bone
interface. The reflective losses can vary from approximately 30-
80% at normal incidence [70]. At low frequencies (approximately
500 kHz and lower), reflective losses dominate the total loss ob-
served through human skull bone [70]. At higher frequencies scat-
tering and absorption play a greater role, making it very diffi-
cult to transmit frequencies greater than 1 MHz through the skull
4 Dissertations in Forestry and Natural Sciences No 67
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Rat SkullMouse Skull
1 mm
Rabbit Skull
10 mm
Human Skull
Approximate Wavelength
of Sound in Bone
Approximate Wavelength
of Sound in Bone
λ0.5MHz ≈ 6 mm
λ0.5MHz ≈ 6 mm
λ1MHz ≈ 3 mm
λ1MHz ≈ 3 mm
Figure 2.1: (Top) Micro CT images of fragments of mouse, rat and rabbit skulls showing
relative sizes and internal structure. (Bottom) CT image of a human skull bone. Scale bars
showing relative size of the wavelength of sound in bone at 0.5 and 1 MHz are shown.
bone [70], except through certain acoustic windows (Section 2.3.1).
The absorptive losses raise an additional concern. Because bone ab-
sorbs ultrasound energy at a much higher rate than the surround-
ing tissue there is the potential for hot spots, particularly at the
scalp/bone interface where the ultrasound energy is the highest. In
therapeutic processes, this means that the temperature at the bone
interface could surpass the temperatures achieved at the transducer
focus, even when low frequencies are employed [50].
Distortion of the ultrasound beam increases with frequency as
the phase shifts become significant relative to the small wavelengths
associated with higher frequencies. Total losses through the skull
Dissertations in Forestry and Natural Sciences No 67 5
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Figure 2.2: (Left) Characteristic pressure profile of a purely standing wave field. Spacing
between subsequent anti-nodes or nodes is 12 λ. (Right) Saggital T2*w image of a rat
brain after high power ultrasound treatment with microbubbles, showing standing wave
patterns of damage. The arrow indicates the direction of the ultrasound propagation.
bone also generally increase with frequency, although transmis-
sion can improve if resonances arise due to specific bone thick-
ness/wavelength relations (e.g. thickness = 12 λ) [1, 70].
When long sonications are used the highly reflective interfaces
of the human skull can give rise to standing waves (Fig. 2.2). The
potential for these to form in the skull cavity [14, 19], or in the
bone [50], has been demonstrated. Standing waves can result in
secondary foci and undesired heating/exposure of healthy tissue.
Multiple reflections can also occur between the transducer and the
skull, contributing to phase distortions at the focus [45].
Thus the skull bone presents a major obstacle for both ultra-
sound imaging and therapy. The following sections will discuss the
techniques for addressing the skull bone in diagnostic and thera-
peutic ultrasound.
2.3 ULTRASOUND IMAGING TECHNIQUES IN THE BRAIN
Ultrasound imaging in the brain faces several restrictions. The use
of short, diagnostic pulses eliminates concerns about standing wave
and skull heating. However, the skull bone still distorts the ultra-
sound beam and reduces the signal strength. As such, the majority
of brain imaging is done intraoperatively or through thinner re-
6 Dissertations in Forestry and Natural Sciences No 67
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ANTERIOR
POSTERIOR
Newborn Skull Adult Skull
Temporal Windows
Suboccipital Window
Anterior Fontanelle
frontal bone frontal bone
frontal bone
parietal bone parietal bone parietal bone parietal bone
occipital bone
Figure 2.3: Illustration of the top view of (left) a newborn skull and (right) an adult skull,
showing the available imaging windows: the anterior fontanelle, the temporal windows
and the suboccipital window.
gions of the bone.
Ultrasound images of the brain are most easily captured intra-
operatively. With the presence of burr holes or a craniotomy win-
dow, direct imaging of the brain can be performed without con-
cerns about the skull bone [9, 13]. In addition to visualizing brain
lesions [13], intraoperative brain ultrasound can provide a means
to guide interventions [78, 238]. The major disadvantage to this ap-
proach is that a bone window is required, which excludes a large
number of patients from this technique.
2.3.1 Imaging Through the Temporal Window
More commonly, ultrasound imaging of the brain is performed
through acoustic windows in the skull. In newborns the anterior
fontanelle (Fig. 2.3) provides an acoustic window through which
ultrasound images can be obtained [62,199]. However, in adults this
window is closed and transcranial ultrasound imaging is most com-
Dissertations in Forestry and Natural Sciences No 67 7
O’Reilly M.A.: Methods for FUS-Induced BBB Disruption
monly performed through the temporal or suboccipital windows
(Fig. 2.3) where the skull bone is least perturbing. Transtemporal
Doppler imaging of the middle cerebral artery was first demon-
strated in 1982 [2], and both transtemporal and suboccipital ul-
trasound imaging have been employed in hundreds of studies at
frequencies typically ranging from 2 - 4 MHz [21, 116, 190, 211].
Transcranial Doppler is the most common type of transcranial ul-
trasound and has been very widely researched due to its appli-
cations for diagnosis of stroke and assessment of recanalization
[28,211,217]. Patients have access to ultrasound much more quickly
than other imaging techniques, and speed of assessment is critical
for stroke patients. By imaging through thin bone windows, the
attenuation of the ultrasound and the induced phase delays are
minimized. However, image quality can still be poor if phase shifts
are not accounted for, and each imaging window has a limited field
of view [211].
2.3.2 Shear Wave Imaging
A more recently proposed technique for imaging in the brain makes
use of the shear wave conversion properties of bone. Longitudinal
waves passing through the skull bone undergo conversion to lon-
gitudinal and shear wave components for all non-normal angles of
incidence (Fig. 2.4). Upon exiting the skull bone, the shear waves
convert back to longitudinal form. Transition to a purely shear wave
mode of transmission occurs at an incident angle close to 30◦, the
critical angle for the longitudinal wave [46, 82]. While the longitu-
dinal speed of sound in the skull bone is close to double that of
water, the shear speed of sound in skull bone is very close to the
speed of sound in water, at approximately 1500 m/s [251]. Since
the shear speed is closer to that in water, foci produced by shear
waves experience less distortion due to refraction effects and the
inhomogeneous propagation through the skull than longitudinal
waves [46]. While the attenuation of shear waves in bone is much
higher than longitudinal waves [257], the closer acoustic impedance
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Tissue
Bone
Tissue
L
LS LL
S L
θ 6= 90◦
Figure 2.4: Illustration of shear mode conversion at a tissue/bone interface. Longitudinal
waves (L) in the tissue or liquid develop shear modes (S) in bone for non-normal angles
of incidence. Exiting the bone, two longitudinal components with different phase are
formed: the longitudinal component from the shear mode in bone (LS) and the longitudinal
component from the longitudinal mode in bone (LL).
match with water of shear mode propagation reduces the reflective
losses, allowing reasonable transmission to be achieved [251]. At
the higher incident angles associated with shear modes, the signal
reflecting from the skull is not captured by the transducer, which
avoids the complication of overlapping reflections from the skull
and intracranial target, as well as multiple reflections between the
skull and transducer.
Axial transcranial shear mode imaging, mechanically scanned
to generate a b-mode image, has been demonstrated in ex vivo skulls
[270] and a-mode imaging has been demonstrated in humans as a
means for monitoring brain shift, with good correlation with MRI
[252]. The shear mode imaging technique is a subject of on-going
research, but shows potential for brain imaging.
2.3.3 Future Applications: Passive Cavitation Mapping
Acoustic cavitation describes the oscillations of either vapour or gas
filled cavities within a liquid [161]. Vapour-filled cavities can be
Dissertations in Forestry and Natural Sciences No 67 9
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nucleated in fluids or tissue during the negative pressure phase of
an ultrasonic wave. Ultrasonically-induced cavitation was first de-
scribed in the 1950’s by Noltingk and Neppiras [162, 164]. The col-
lapse of these cavities, referred to as inertial cavitation, is associated
with high pressures and temperatures. Stable cavitation is much
less violent and refers to the oscillation of the bubbles without, or
prior to, collapse. Stable cavitation can be more easily achieved by
the injection of preformed microbubble (MB) contrast agents into
the circulation, rather than nucleation of transient cavities in the
tissue. Under sufficient driving pressure, a stably cavitating bubble
within an ultrasound field emits harmonics (e.g. n f0, n= 2, 3, 4 )
of the excitation frequency, as well as sub ( 12 f0) and ultraharmonics
(n f0, n= 32 ,
5
2 ,
7
2 ) [161]. Subharmonics may arise beyond a threshold
pressure, which is minimized for free bubbles near resonant size at
the subharmonic frequency [64,160]. Non-spherical modes of oscil-
lation may also contribute to nonlinear emissions [61, 161]. Inertial
cavitation is associated with wideband emissions [161]. Cavitation,
both inertial and stable, is associated with a number of bioeffects,
which will be discussed in Section 2.6.2
Cavitation can be both actively or passively detected [10, 193].
Active techniques use a pulse echo transducer to monitor the re-
gion where cavitation is expected. If transient cavitation occurs the
diagnostic pulse will reflect off of the generated bubble cloud and
a change in the backscattered signal will be detected [193]. The
same technique can be used to detect changes in backscattered sig-
nal following the injection of microbubbles. Alternatively, a passive
transducer can be employed which monitors the field and records
the signal following sonications from the active transducer [10]. For
therapeutic purposes, passive cavitation mapping is a particularily
attractive solution as long insonations can be monitored and there
is no need to gate the therapy pulse in order to send an active
pulse echo. Cavitation activity can be identified by an increase in
the scattered signal in the time domain, and by changes in har-
monic, sub/ultraharmonic and wideband emissions bands in the
frequency domain.
10 Dissertations in Forestry and Natural Sciences No 67
Ultrasound and the Brain
The information obtained from a single element cavitation de-
tector is limited. Cavitation events can be detected, but their source
location and the time at which they occurred are impossible to de-
termine, as events do not necessarily occur during the first cycle
of a sonication. However, using an array of multiple receivers, the
received signals can be beamformed (delay and sum) to map the
source locations in space [79, 165, 166, 197]. This approach allows
the cavitation activity of multiple sources to be mapped over time
and could be a useful tool for tracking treatment progress in cavi-
tation enhanced therapies. The process is simple. An image grid is
created which contains the location for each pixel of the resulting
map. Stepping through the grid point by point, delays are applied
to each receiver signal based on the distance from receiver to grid
point and the receiver signals are summed. If a source is located
at the grid point the signals should be maximally in-phase follow-
ing the applied delays and constructive interference should amplify
the signal. If no source is located at the point, phase cancellations
should minimize the resulting summation. The overall image can
then be generated by assigning each pixel a representative inten-
sity based on the waveform summation at that point. Integration
over a portion of the intensity waveform is a good way to represent
relative contributions, as it gives value to both the length of time
for which a source cavitates and the magnitude of the cavitation
activity [79,166]. The Time Exposure Acoustics algorithm proposed
by Norton and Won [166] for seismic imaging includes a term to re-
move the ’D.C. bias’ which arises from integration over the intensity
summation.
In the brain, the skull bone makes cavitation mapping more
challenging. Gaˆteau et al. [75] induced single cavitation events in
vitro through an ex vivo human skull and used the resulting bub-
ble emissions to correct phase distortions from the skull. If the
delays through the skull are known a priori, or can be calculated,
passive cavitation mapping could be used in the brain. In addition
to monitoring of therapeutic applications, passive cavitation map-
ping could potentially be used to map the vasculature if used in
Dissertations in Forestry and Natural Sciences No 67 11
O’Reilly M.A.: Methods for FUS-Induced BBB Disruption
Spherically-Curved TransducerPlanar Transducer
Lens
Phased Array
Delay = τ1
τ2 τ3 etc...
Figure 2.5: Focusing techniques. (Left) focusing through an acoustic lens, (center) geo-
metric focusing, (right) electronic focusing.
combination with circulating microbubbles.
2.4 FOCUSED ULTRASOUND
Focused ultrasound (FUS) is an application of ultrasound in which
the wave energy is concentrated to provide high gains and local-
ized energy deposition. The focusing of the ultrasound can be
achieved using lenses, curved transducer geometry or electronic
focusing (Fig. 2.5). Electronic focusing is used with phased arrays,
where phase delays are applied to the driving signals of each in-
dividual array element so that the waves propagating from each
element arrive at the desired focus in-phase. With FUS, the ultra-
sound interacts constructively at the transducer focus while phase-
cancellations everywhere else minimize effects outside of the de-
sired focus (Fig. 2.6). Therapeutic ultrasound typically requires
much longer pulses (milliseconds to seconds) than diagnostic ul-
trasound (microseconds) in order to induce the desired bioeffects.
Investigations into the therapeutic potential of FUS began in the
1940’s [133,134]. Since, FUS has been investigated in a wide range of
applications. Currently, non-invasive treatment of uterine fibroids
[84, 219, 223] is the only FDA approved usage of non-invasive FUS,
although an intra-operative application for cardiac ablation [156]
has clearance. However, prostate [4, 51, 76], breast [92, 103, 255],
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Figure 2.6: (Top)Simulated normalized pressure profile for a 1 cm diameter, circular planar
transducer operating at 1 MHz. (Bottom) Simulated normalized pressure profile for a 4
cm diameter, spherically focused transducer with f-number=1, operating at 1 MHz
bone [29,255], liver [107,255], kidney [107,256] and brain treatments
[72,78,140,142], among others, have been performed in Asia, Europe
and North America. FUS allows large amounts of energy to non-
invasively be deposited deep into tissues to create necrosis or other
tissue modifying effects, with minimal effect on the tissue between
the transducer and the focus.
Like diagnostic ultrasound, transcranial FUS faces challenges
arising from propagation through the skull. Skull heating, beam de-
focusing and standing waves must all be considered in transcranial
FUS. These have been overcome through a variety of techniques.
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2.5 CIRCUMVENTING THE SKULL
Focused ultrasound brain treatments in humans date to the late
1950’s, when Fry and Fry performed neurosurgical interventions in
over 100 patients [72]. To facilitate the treatments, a bone window
was created. In the early 1990’s, this was still the approach for FUS
brain treatments [78], as treatments through the skull were believed
impossible. However, the limitations of a bone window approach
and the invasiveness of the procedure greatly inhibited adoption
of brain FUS into wider use, despite early clinical studies show-
ing some positive ultrasound effects [72, 78, 83]. Bone replacement
materials with superior acoustic properties have been proposed for
brain FUS applications [226]. However, the use of a bone window
requires an invasive surgical procedure. Additionally, a bone win-
dow can limit the size of the treatable region [78, 184].
In 1998, Hynynen and Jolesz demonstrated the feasibility of fo-
cusing through a human skull [97] with clinically relevant large
2D arrays. They demonstrated that an intact focus could be ob-
tained through the human skull when frequencies below 0.5 MHz
were employed. At higher frequencies, they used a multi-element
phased array to correct for the phase shifts induced by the skull and
obtained a sharp transcranial focus at 1.58 MHz. At the same time,
a numerical study by Sun and Hynynen proposed to solve the skull
heating problem through the use of lower frequencies, where the
absorption by the skull bone is lower, and by increasing the area
of the skull through which the ultrasound penetrates [220]. By us-
ing a large-aperture array, the amount of energy passing through a
specific point on the skull is minimized, while achieving high fo-
cal gains. The first hemispherical transcranial therapy array was
presented by Clement et al. in 2000 [44]. The array was 30 cm in
diameter with a driving frequency of 665 kHz, and had 64 elements
which could be driven separately to provide phase corrections. Us-
ing this array, lesions were made in rabbit thigh through a human
skull. However, temperature rises in the skull (12-18◦C) established
that active cooling of the scalp and outer skull surface would be
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necessary in practice to keep skull temperatures at a safe level [44].
A number of large aperture arrays have since been developed
for research purposes [11, 94, 176, 177, 215], and two clinical proto-
type systems are available, each with 1024 elements, and operat-
ing at 220 kHz and 650 kHz respectively (Exablate 4000, InSightec,
Haifa, Israel). The highest operating frequency of these arrays is
1 MHz [11]. The increased number of elements in these arrays (up
to 1372 [215]) reduce grating lobes, improve transcranial focusing
and beam steering, and increase the maximum achievable focal in-
tensity through improved phase and amplitude correction. Array
performance increases with increasing number of elements. Opti-
mal center-to-center element spacing to avoid grating lobes is 12λ
or less [241]. Achieving full array population at this spacing can
require a very large number of elements. However, the hardware
requirements to support arrays with large numbers of elements of-
ten make them unfeasible. To reduce hardware requirements, Song
and Hynynen drove the 1372 elements in their hemispherical ar-
ray in lateral mode [215]. By using the lateral mode, the electrical
impedance of the elements is greatly reduced, eliminating the need
for individual matching circuits.
If hardware restrictions impede the implementation of a fully
populated array, a large aperture array can still be achieved using a
reduced number of elements distributed over the whole array aper-
ture. Random population of the array reduces grating lobes and
can result in good array performance with far fewer elements. To
compensate for the reduced number of elements, elements capable
of generating high acoustic powers were used in the 200 element
random array described by Pernot et al. [177].
In addition to allowing focusing through the skull and reduc-
ing skull heating, large aperture arrays also provide sharp focal
spots and reduce the effects of standing waves in the skull. In a
simulation study, Baron et al. [19] demonstrated the importance
of beam focusing in standing wave suppression. Planar, 300 kHz
ultrasound applied transcranially resulted in standing waves. Con-
versely, 2 MHz focused ultrasound did not. The frequency of the ul-
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trasound and the degree of focusing provided by the transducer are
important for avoiding standing waves. Deffieux and Konofagou
[58] found that in simulations of low frequency (0.3-1 MHz) sonica-
tions through primate and human skulls using transducers with fo-
cal numbers close to 1, standing waves were observed near the skull
base and increased with decreasing frequency. A recent study has
shown that small apertures can lead to significant standing waves
both from reflections at the skull base and between the skull and
the transducer [216]. However, for a large aperture, tightly focused
transducer the standing wave effects become negligible [216]. In
addition, modulation of the ultrasound pulse has been proposed
to reduce standing wave effects. Linear chirps [58], sweep frequen-
cies [157] and random phase shifts [221] have all been shown, either
in silico or in vitro , to reduce standing waves.
2.5.1 Phase Correction of Skull Distortions
Several techniques exist to calculate the required phase delays to
be applied to each array element in order to correct for the shifts
induced by the skull. The simplest method, and gold standard for
correcting phase distortions through an ex vivo skull, is through
the use of a hydrophone placed at the focus [44, 97, 212, 224]. The
elements are turned on in sequence and the phase at which each
signal reaches the hydrophone is recorded. The deviation from the
expected phase can then be used to apply corrective lags to the
RF driving signals. Similarly, if an acoustic source is placed at the
focus, the elements of the array can be used in receive mode to cap-
ture emissions from the source. Again the phase and amplitude
can be recorded and used to determine the CW- driving signals,
or when short burst are used a time-reversal mirror [68, 224] can
provide additional information about the optimal RF signals as a
function of sonication duration. Focusing can be further improved
using a spatio-temporal filter [222], which allows greater control
of the acoustic field surrounding the focus. Although these tech-
niques can provide good phase correction, they are difficult to im-
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plement in vivo due the need to place either a receiver or a source
at the focus. One proposed technique is to use a cavitating source
for the time-reversal mirror [117, 178]. Liquid nanodroplets could
be injected into the circulation and then vaporized by a poorly fo-
cused beam, using the resulting emissions to calculate the necessary
phase corrections to produce a better focus [117]. An alternative
method has been proposed where a short pulse is used to induce
a single cavitation event [178]. In ex vivo skulls, this has resulted
in restoration of 97% of the pressure achievable with hydrophone
based correction [75], higher than other non-invasive techniques for
phase correction. At present it is unclear what the effects of induc-
ing short inertial cavitation events in the brain are. Of additional
concern is the fact that early studies on the effects of FUS in the
brain found that cavitation readily occurs at brain/ventricle inter-
faces even when these regions are outside the transducer focus [71].
The variability of cavitation thresholds through different regions of
the brain suggest that until these thresholds are better understood,
intentionally inducing cavitation in the brain may be unsafe.
The use of pre-operative image information to correct phase
distortions was first proposed by Hynynen and Sun [105]. The
skull geometry was obtained from MR or CT images and input
into a three layer computational model (water, skull and brain tis-
sue). The propagation of the ultrasound through the model was
then simulated using homogenous tissue properties based on lit-
erature averages, and corrective phase delays were applied to the
transducer elements as with the other phase correction techniques.
This approach was later improved to assign average bone proper-
ties (speed of sound) for each skull location based on CT bone den-
sity information [43] and finally heterogenous bone properties also
based on CT data [12, 49], and considering both longitudinal and
shear modes of propagation [182]. Simulation based methods are
entirely non-invasive and have been successfully applied in clinical
treatments [140, 142]. However, the more complete models can be
computational expensive.
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2.5.2 Amplitude Correction of Skull Distortions
In addition to phase distortions, the sound passing through differ-
ent parts of the skull is subject to different losses. Amplitude cor-
rection can be applied to counter this and optimize transducer ef-
ficiency. White et al. [250] described two approaches for amplitude
correction of the signal. The first approach, so called ’amplitude
correction’, aims to achieve equal amplitudes from each driving el-
ement at the focus. Thus, elements generating signals that pass
through regions of the skull that attenuate more are given higher
driving signals. Conversely, elements generating signals that pass
through regions of low attenuation have reduced signals. This ap-
proach has two short-comings. First, hot spots can be created in
the skull bone, as areas with high absorption are being subjected
to more energy. Second, ’amplitude correction’ is electrically inef-
ficient as large amounts of power are being dedicated to elements
with high losses. For the same total electrical input to all elements,
’amplitude correction’ achieves lower focal intensity than no am-
plitude correction [250]. The alternative approach is referred to as
’inverse amplitude correction’. The goal here is to obtain equal
absorption through the skull from each driving element. Thus el-
ements driving signal through regions of higher attenuation are
given lower driving amplitudes and those driving signal through
regions which easily pass ultrasound are given higher driving am-
plitudes. This approach avoids hot-spots in the bone and results in
higher focal intensities than no amplitude correction or ’amplitude
correction’ for the same total electrical input [250]. A simpler im-
plementation of this idea is to drive the array elements with such
powers that uniform intensity is achieved at the skull surface [98].
This approach is used in the current clinical thermal ablation treat-
ments [142].
2.6 THERAPEUTIC EFFECTS AND CLINICAL STUDIES
Biological effects of ultrasound in the brain can be broadly classified
into thermal and non-thermal. Thermal effects have been widely in-
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vestigated and have been used in humans, although not widely, for
over fifty years [72]. Non-thermal effects have been more recently
investigated and many non-thermal applications are currently be-
ing identified. Both thermal and non-thermal effects are discussed
in the following sections.
2.6.1 Thermal Effects
Ultrasound induced hyperthermia describes the modest tempera-
ture rises (42-48◦C) that occur as a result of long insonations. En-
ergy deposition by the ultrasound induces a local temperature rise
which can be maintained for minutes to hours to achieve therapeu-
tic effects. Heat has long been known to have detrimental effects on
the brain. Harris et al. [81] noted that an increase to 42◦C in canine
brain resulted in no neurological deficits. In contrast, animals in
which the brain was heated to 44-46◦C suffered severe complica-
tions, including hemiparesis and death [81]. Similarly, Burger and
Fuhrman [25] found that rabbit cerebral cortex showed increased
ammonia production when exposed to temperatures of 43-44◦C.
The threshold thermal dose for brain damage was measured in
cat brain to be approximately 60 minutes at 42◦C [135]. For rela-
tively short (30 s) ultrasound sonications in rabbit brain, the thresh-
old temperature for tissue damage was found to be 48.4◦C, with a
threshold thermal dose of 17.5 equivalent minutes at 43◦C [150].
Cancer cells in their tumor environment are particularly sensi-
tive to heat, and total body hyperthermia alone or in combination
with other interventions (chemotherapy, radiation and immunother-
apy) has been shown to induce a positive response in many dif-
ferent primary cancers [119]. Marmor and Hahn [137] used ul-
trasound hyperthermia following tumor x-irradiation of skin can-
cers and achieved partial or complete tumor regression in 11 of 18
cases. Shimm et al. [209] demonstrated in two brain tumor patients
that therapeutic temperatures (>44◦C) could be achieved through a
bone window using scanned focused ultrasound [104]. By mechan-
ically scanning the focus the shape and size of the treatment area
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can be controlled [104].
In 1991, Guthkelch et al. [78] conducted a phase I clinical trial
on 15 patients with primary brain tumors. Ultrasound hyperther-
mia with a target temperature of 42.5◦C was used in combination
with radiation therapy. This was the only phase I trial published
on ultrasound hyperthermia for brain cancer treatment. Available
autopsy data from some of the study participants showed positive
effects of the combined treatment with visible tissue necrosis in the
tumor volume. However, the study had several limitations. First,
as in the study by Shimm et al. [209], the treatment was performed
through a craniotomy window, which both necessitated an invasive
surgery and limited the treatable region of the brain. Second, both
studies used thermometry probes placed in the brain to monitor
temperature rises. The placement of catheters in the brain tissue is
invasive, and the catheters only provide temperature information
at discreet points in the brain. Guthkelch et al. [78] found that in
two patients the autopsy data showed the necrosed treatment vol-
ume extending past the tumor margin into healthy adjacent tissue.
Such over-treatment could potentially have been avoided if more
advanced temperature monitoring techniques had been available.
Thermal ablation is the other thermal FUS application. The ob-
jective in ablation is to use high intensities to quickly obtain high
temperatures (55-60◦C). There were a few early studies where FUS
was used to ablate brain tissue. Fry and Fry [72] treated close to
50 patients for conditions including Parkinson’s disease, intractable
pain and phantom limb pain. Treatments were performed through
a craniotomy window and the study describes a positive response
to many of the treatments, although not always a permanent one.
Heimburger et al. [83] investigated the feasibility of treating pri-
mary and metastatic brain tumors (20 patients) with focused ul-
trasound through a craniotomy. In a few patients, moderate in-
tensities and low frequencies were used to treat through the skull
bone. However, the transcranial treatments were associated with
skin burns and were discontinued. Metastatic tumors treated were
unresponsive to the treatment.
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Several developments kept brain FUS from being abandoned.
First was the introduction of MRI as a guidance and monitoring
modality for FUS treatment. It was demonstrated in the early 1990’s
that MRI could be used both to monitor temperature rises dur-
ing FUS hyperthermia and to guide treatments and evaluate out-
come [47, 95, 96]. MRI thermometry is now sufficiently fast that
treatments can be controlled real-time using a feedback control al-
gorithm [183, 210]. MR-thermometry of the brain during FUS can
be used to predict the level of damage to the tissue [244]. What
is possibly most significant is that MR-thermometry is sensitive
enough to detect temperature rises below the threshold for irre-
versible damage [106] and can monitor temperature rises in ’at risk’
zones, such as next to the skull [143].
The advances in treatment monitoring combined with demon-
stration of the feasibility of transcranial FUS [97] greatly increased
the push towards clinical use. Several primate brain ablation stud-
ies have been published [98, 138, 144] including two studies per-
formed transcranially [98, 138]. One group investigating a high fre-
quency (1 MHz) approach to transcranial therapy has recently been
validating their 512 element array in a cadaver study [11]. In ad-
dition to these investigations, in the past 6 years, results from five
clinical investigations of brain ablation have been reported.
In 2005, Park et al. [174] presented results from FUS treatment
of a single case of anaplastic glioma through a craniotomy with ul-
trasound guided system. Full study details are unavailable, but an
improvement in patient symptoms was observed along with some
tumor shrinkage. The full study was never published.
In 2006, results from the treatment of 3 glioma patients with a
craniotomy window using an in-bed focused ultrasound system de-
signed for treating uterine fibroids (ExAblate2000, Insightec) were
reported [184]. This approach was based on previous brain hy-
perthermia studies through a craniotomy [78, 209] and the demon-
stration of thermal ablation in a primate model through a cran-
iotomy [144]. A feasibility study published after the fact reported
successful ablations in 10 pigs without complications [48]. Despite
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this, the clinical investigation was unsuccessful. A technical mal-
function prevented one patient from receiving therapeutic levels of
ultrasound. One patient was treated without complication, but the
craniotomy window limited the treatment volume and surgical re-
section was required. In the final patient, a secondary focus formed
in the brain, possibly a result of reflections from the skullbase, caus-
ing hemiparesis.
The most recent three clinical investigations of FUS brain ab-
lation [63, 140, 142] have all used ExAblate transcranial ultrasound
systems (InSightec). Both systems are hemispherical arrays oper-
ating at approximately 650 kHz. The most recent generation de-
vice has 1024 elements, while the previous device has 512. The 512
element device was used at in Boston to treat 3 glioblastoma pa-
tients [142]. Temperatures of 48-51◦C were achieved in two patients.
The third patient experienced some discomfort and the treatments
were terminated before significant temperatures could be achieved.
The power available during treatment was limited with the array
used, but the study had several key findings. Importantly, the study
demonstrated that a transcranial focus can be achieved in vivo in
humans, that temperature rises at the focus and the skull surfaces
could be appropriately mapped, and that temperatures at the skull
were sufficiently low by comparison to the focus to make ablation
feasible.
In Zurich, 9 patients have been treated for chronic pain [140]
using the 1024 element ExAblate system. Temperatures between 50
and 60 ◦C were achieved in the patients, and lesions (3-5 mm in
diameter) were visible on T2w MRI 24 to 48 hours post treatment.
Lesions were precisely located and early pain relief was reported. It
is unclear whether full ablation was achieved and follow-up results
have not yet been published.
Most recently, in Virginia, transcranial brain ablation for the
treatment of essential tremor has been investigated [63]. Only pre-
liminary results have been reported, however reduction of the tremor
has been observed without treatment complications [63].
One limitation which still remains for thermal ablation in the
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brain is the limited brain region which can be treated. Due to the
high absorption of the skull bone, transcranial ablation is feasible
only for regions in the midbrain, with treatments close to the skull
resulting in greater temperature rises in the bone than at the focus
[50, 182].
2.6.2 Cavitation Enhanced Bioeffects
Acoustic cavitation is known to enhance tissue heating during FUS
[87, 93, 214]. In addition, cavitation can enhance a number of other
bioeffects. For example, circulating preformed microbubbles under
different ultrasound exposure have been shown to increase hemol-
ysis [56], increase hemorrhage [55] and disrupt the blood brain bar-
rier [101].
Inducing inertial cavitation in brain tissue is generally avoided.
The threshold for inertial cavitation in the brain varies across the
different structures, with early studies showing that cavitation most
often occurs at tissue/ventricle boundaries [71]. As a result, cav-
itation cannot be presently induced in the brain without risk of
damage to tissues outside the target volume. One patient received
cavitation-enhanced treatment in Boston and had an adverse event.
The patient died a few days following treatment due to bleeding
in the brain which may or may not have been a result of the treat-
ment [110].
Preformed microbubbles have the ability to cause a number of
bioeffects and can be more safely employed in the brain than iner-
tial cavitation of the tissue. Microbubbles used in FUS are the same
as those used in diagnostic ultrasound. They are micron-sized en-
capsulated gas bubbles. Commercially available microbubbles con-
sist of a perfluorocarbon gas surrounded by an albumin (Optison,
GE Healthcare) or phospholipid shell (Definity, Lantheus Medical
Imaging, Sonovue, Bracco Diagnostics, Inc,). Microbubbles can be
stably excited at pressures well below the threshold for cavitation
in the brain tissue.
More recently, liquid nanodroplets have been investigated for
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diagnostic and therapeutic purposes. Liquid nanodroplets are acous-
tically transparent perfluorocarbons droplets which can be vapor-
ized in situ to produce microbubbles [117, 118]. By vaporizing the
droplets at the transducer focus, near field interactions, which can
occur with microbubbles [146], are avoided. Droplets can be man-
ufactured over a range of sizes for which their threshold for va-
porization to microbubbles is lower than their inertial cavitaiton
threshold [200]. This affords some flexibility in tailoring the con-
trast agents to specific applications.
The use of microbubbles or liquid nanodroplets could facili-
tate treatment of near-skull regions of the brain in which ablation
and hyperthermia by ultrasound alone are not feasible. McDan-
nold et al. [146] demonstrated that microbubbles combined with
ultrasound could be used to induce lesions in rabbit brain. In
addition, both microbubbles and droplets can be manufactured to
contain a drug payload delivered when the carrier is destroyed in
situ [65, 66, 185]. The most common therapeutic application of mi-
crobubbles in the brain is in FUS induced blood brain barrier dis-
ruption. This will be discussed in detail in the following chapter
(Chapter 3).
At present, microbubbles and nanodroplets have not been used
for ablation or drug delivery purposes in the brain in humans.
2.7 OTHER APPLICATIONS OF FUS IN THE BRAIN
Over 15 million individuals worldwide suffer strokes each year and
more than 5 million die from stroke [136]. Ultrasound has been
known for over 30 years to have an effect on clot lysis [229]. Ex-
tensive research has been conducted in vitro and in vivo in animal
models and is well documented in review articles [54, 179]. In hu-
mans, several studies have used ultrasound to enhance effects of
lytic agents for stroke [5, 53, 158]. Tissue plasminogen activator
(tPA) is a known lytic agent which is effective for treating stroke
if administered within three hours of onset [163]. The effects of
tPA can be increased when combined with ultrasound [69]. In-
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travenous (IV) administration of tPA is a standard treatment for
stroke, and clinical trials using transcranial Doppler, with or with-
out microbubbles, to enhance tPA effects resulted in improved re-
canalization rates and no increase in hemorrhage risk [5, 158, 230].
However, one study investigated the effects of low frequency pla-
nar ultrasound on tPA mediated lysis [53]. That study was prema-
turely terminated following abnormally high hemorrhage rates in
the contralateral hemisphere. It was later suggested that the con-
tralateral hemorrhage may have been due to standing waves from
skull reflections [19]. Because tPA alone has been associated with an
increase in intracranial hemorrhage [163], there is an interest in de-
velopment of alternative treatments. Ho¨lscher et al. [86] presented
preliminary in vitro results at conference demonstrating that clots
could be lysed using ultrasound alone, delivered through ex vivo
human skulls with the use of a clinical prototype transcranial FUS
system (ExAblate4000, InSightec). Recently, Culp et al. [52] have
demonstrated clot lysis in rabbit brain using ultrasound and mi-
crobubbles. Clot reduction was improved using US and microbub-
bles over tPA alone, or US and tPa. No increase in hemorrhage was
observed with the use of US and microbubbles. Based on the in
vitro work of Wright et al. [254], investigations in a rabbit model of
stroke have demonstrated that FUS alone can be used for clot dis-
solution [27]. The mechanism for this dissolution is thought to be
inertial cavitation within the clot [254]. Due to the large number
of individuals impacted by stroke, and promising preclinical and
clinical results, ultrasound treatment of stroke will continue to be a
highly investigated area of research.
Recently, the application of ultrasound for neuromodulation has
also been investigated [232, 237, 267, 268], and transcranial ultra-
sound could provide a non-invasive alternative to deep brain stimu-
lation. In 2008, Tyler et al. [237] demonstrated that ultrasound could
be used to stimulate neurons in hippocampal slice cultures. Func-
tional changes demonstrated transcranially in mouse brain [232]
were consistent with early experiments demonstrating temporary
functional changes can be safely induced in feline brain follow-
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ing ultrasound exposures [72]. Recently it has been demonstrated
that stimulation of the thalamus using FUS can reduce the recovery
time from anesthetic in rats [268]. Continued research may find ul-
trasound neuromodulation treatment effective for a range of brain
disorders. However, a great deal of work remains to improve under-
standing of the mechanisms involved in these functional changes.
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3 Focused Ultrasound Dis-
ruption of the Blood-Brain
Barrier
3.1 THE BLOOD BRAIN BARRIER
The blood-brain barrier (BBB) is a specialized structure that restricts
passage of molecules from the vasculature to the brain tissue. Fig-
ure 3.1 illustrates the neurovascular units that make up the BBB.
Vasculature in the brain differs from elsewhere in the body by two
features. First, in brain endothelial cells, there are a reduced num-
ber of vesicles for active transcellular transport [195]. Transcellu-
lar passage for therapeutics is therefore limited to small lipophillic
molecules [3]. Passage of essential nutrients and proteins occurs via
specialized transport proteins or receptor-mediated transcytosis [3].
The second feature that limits the delivery of agents into
the parenchyma is the presence of tight junctions (TJs) between
endothelial cells which prevents paracellular passage [195]. It
is thought that astrocytes may be responsible for the formation
of tight junctions or of upregulation of tight junction functions
[109, 194]. Several proteins have been identified as important com-
ponents of the TJs. Zonula occluden ZO-1 was the first to be iden-
tified [218], followed by other zonula occludens, occludin [74], and
claudin-1 and claudin-2 [73]. Expression levels of these proteins can
be an indicator of tight junction permeability [85]. The main route
for passage of water-soluble molecules would be paracellular [3] if
not for presence of TJs.
Due to the TJs, the BBB prevents over 98% of neurotherapeu-
tics from passing into the brain parenchyma [171]. There are sev-
eral techniques for circumventing the BBB. The neurosurgical ap-
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Figure 3.1: The neurovascular unit
proaches are the most invasive and involve injection of a drug into
the brain tissue or ventricle [171]. The drug can then diffuse to a
limited degree through the surrounding interstitium. A less inva-
sive approach involves an intracarotid injection of a hyperosmotic
solution such as urea [24] or Mannitol [196]. However, this ap-
proach opens the BBB globally in the region fed by the artery, ex-
posing the whole brain to pathogens. In addition, injection of Man-
nitol has been shown to cause permanent neurological changes,
which calls into question its safety [196]. A number of other agents,
when injected via the carotid artery in sufficient quantities, will
induce BBB disruption (BBBD), including Hypaque [205], distilled
water [205], ethyl alcohol [205] and microbubbles [159, 192].
Focused ultrasound disruption of the BBB provides an advan-
tage over other techniques in that it is non-invasive, image-guided,
localized and transient. The following sections will examine FUS
induced BBBD in greater depth.
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3.2 HISTORICAL PERSPECTIVE
The effects of ultrasound on the BBB have been investigated since
the 1950’s. In 1956, Bakay et al. first reported a reversible zone of
BBBD around ultrasound induced lesions in cat brain [16]. Cats
were sonicated with pulsed ultrasound through a cranial window
and survived for 10 minutes to 5 days post treatment. During the
first few hours post treatment an additional zone of edema and
Trypan blue staining was visible around the lesion. This subsided
with time and by 4-5 days post treatment, Trypan blue staining
was only visible at the lesion margin. In 1960, also in a cat model,
Ballantine et al. demonstrated ultrasound disruption of the BBB
with hemorrhage but without inducing a discrete lesion [17]. From
this, they postulated that BBBD may be possible with US without
producing a lesion if appropriate acoustic parameters are used.
Between 1960 and 2000 there were very few investigations into
US-induced BBBD. In 1965, Shealy and Crafts found that a dam-
aged BBB is more susceptible to re-injury than normal brain tis-
sue [205]. In brain tumors, the BBB is leaky and the blood-tumor
barrier (BTB) is much less effective at preventing passage than the
intact BBB. These findings suggested that regions with impaired
BBB, such as the BTB, could be more susceptible to the effects of
FUS, allowing brain regions with pathology to be treated while
sparing healthy tissue. It was later shown that the intensity thresh-
old for BBBD also varies within healthy brain between different
brain structures [175]. The major limitation with early studies was
that high intensity focused ultrasound (HIFU) always resulted in
some level of damage.
In 1995, Vykhodtseva et al. showed that by altering acoustic pa-
rameters, different histological effects could be produced. In some
cases BBBD was achieved without histological damage. However,
disruption and damage were inconsistent. Similarly, in 2002, Mesi-
wala et al. found that pulsed HIFU could be used to disrupt the
BBB, in some cases without damage [155]. However, as with the
study by Vykhodtseva et al., consistency of disruption and damage
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could not be achieved.
As an alternative to HIFU, Hynynen et al. proposed the use
of microbubble contrast agents in combination with lower intensity
ultrasound to disrupt the BBB [101]. The addition of circulating
microbubbles (MBs) lowered the threshold for disruption to two
orders of magnitude less than the threshold for thermal damage in
the brain. At lower pressures, tissue damage could be avoided, al-
though some extravasated red blood cells (RBCs) were noted. When
pressures were low enough to avoid tissue damage, the BBB was
found to close fully within 24 h. By comparison, Mesiwala et al.
found the BBB to be closed by 72 h with their approach [155]. Hyny-
nen et al. were also the first to use MRI for guidance and monitor-
ing of FUS BBBD [101]. MRI guidance and monitoring of FUS is
now widely used. Additionally, the majority of studies since 2001
have used microbubbles as a mediating agent for FUS BBBD. In
the absence of microbubbles, a thermally induced increase in brain
endothelial cell permeability has been demonstrated in vitro [32].
However, in vivo the threshold for thermal BBBD has been shown
to be at or above the threshold for thermal damage, resulting in
damage whenever BBBD is thermally induced [150], at least with
the sort of exposures tested.
Since 2001 there have been 91 english language, peer-reviewed
journal publications on ultrasound induced BBBD, 26 in 2010 alone.
Table 3.1 provides a summary of the study parameters and major
findings for all US BBBD peer-reviewed journal papers to date. In
addition to these, there have been a number of conference presen-
tations and publications. The peer-reviewed literature and some
recent high interest conference presentations and publications will
be discussed in the following sections.
3.3 CELLULAR MECHANISMS OF FUS BBBD
Four possible mechanisms for molecular transfer across the FUS
disrupted BBB have been identified: trancytosis, transendothelial
openings, interendothelial clefts via opening of tight junctions, and
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passage through the endothelial lining if damage occurs [208]. Ac-
tive vesicular transport has been identified as the first transport
route following FUS [100]. Transcellular transport has been in-
dicated in several electron microscopy studies by an increase in
the number of vesicles present in the endothelial cells of the BBB
[59,100,102,206–208,269] and BTB [258] following FUS. In addition,
FUS has been shown to transiently upregulate caveolae proteins in
the BTB (caveolin-1 and caveolin-2) [258] and in the BBB (caveolin-1,
caveolin-2 not investigated) [59], further demonstrating the induc-
tion of an active transport mechanism. Sheikov et al. noted the
presence of cytoplasmic channels [208], and postulated that these
could arise from fusion of several vesicles [206].
Paracellular passage through interendothelial clefts and dis-
rupted tight junctions is the other mechanism for transfer to the
parenchyma. This mechanism has been the subject of a number of
studies. Opening of intercellular clefts has been visualized by elec-
tron microscopy [100, 102, 155, 206–208, 247, 271]. In addition, tight
junction proteins ZO-1, occludin, claudin-1 and claudin-5 have all
been shown to be transiently down-regulated in the BBB [108, 207]
and the BTB following FUS BBBD [67, 204, 247, 271, 272], with a re-
duction of mRNA expression of these proteins [204, 247, 271, 272].
Recently, Jalali et al., showed FUS induced phosphorylation of AKT,
suggesting activation of the AKT signaling pathway which is im-
plicated with tight junction regulation [108]. Gap junction pro-
teins connexin-36 (neurons) and connexin-43 (astrocytes), which are
known to interact with tight junction protein ZO-1, reorganize fol-
lowing FUS BBBD, but do not change expression levels [8]. In vitro
in brain microvessel endothelial cells (BMECs), the concentration of
Ca2+ has been shown to change following sonoporation, immedi-
ately in cells adjacent to MBs and with delayed modulation in those
not adjacent to MBs [172]. Reorganization of gap junction proteins
may also assist restoration of such ion imbalances resulting from
FUS [8].
Imaging of mouse and rat microvasculature during BBBD has
been achieved with multi-photon microscopy [33, 186, 187]. Both
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vasoconstriction [33, 186, 187] and vasodilation [33] have been re-
ported in response to FUS and MBs. Vasoconstriction appears to
occur only in arterioles [187]. Different leakage characteristics have
also been described. Leakage from distinct focal points along the
vessel and diffuse leakage along the entire vessel have both been
observed, which may correlate with leakage from tight junctions
vs. transcellular transport [187].
3.4 EFFECTS OF ACOUSTIC AND MICROBUBBLE PARAME-
TERS
There have been a number of investigations of the effects of differ-
ent acoustic parameters on BBBD. Disruption effects, damage and
duration of BBBD have been known since the first studies [101] to
increase with increasing treatment pressure. In general this is con-
sistent with the literature to date. However, at 1.08 MHz, Chopra et
al. observed a diminishing effect of increased pressure on MRI en-
hancement values beyond approximately 0.5 MPa [42]. The sonica-
tions in this study were long (≈300 s) and above 0.5 MPa a substan-
tial percentage of sonications resulted in tissue damage observed in
histology. Thus the ability to deliver agents across the BBB may
only increase with pressure below the threshold for generating a
lesion. In that study, treatment duration was also seen to have an
effect on disruption level and damage [42]. As with pressure, the
effects of increasing the treatment duration appeared to level off
beyond 600 s with a single bolus injection of MBs. These treatment
durations were also associated with increased levels of damage to
the tissue.
The threshold to induce BBBD increases with increasing fre-
quency. McDannold et al., found the threshold for disruption to be
approximately MI=0.46, where MI is the mechanical index (peak-
negative pressure/
√
frequency) [149]. This relationship was deter-
mined for 20 s sonications and 10 ms pulses repeated at the rate
of 1 Hz but may be different when pulse length (PL) and duration
change. Additionally, the data used examined frequencies ranging
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from 0.26-2.04 MHz, and one study at 28 kHz found that this re-
lationship may not hold true for very low frequencies [129]. Mc-
Dannold et al. also observed more RBC extravasations per unit
area at higher frequencies. At 0.26 MHz, Hynynen et al. demon-
strated that consistent BBBD without RBC extravasations could be
achieved [102].
At short pulse lengths (<1 ms) the disruption level is reduced
[22, 37, 149, 169]. Bing et al. reported an increase in MRI measured
enhancement with increasing pulse length, suggesting a possible
radiation force mechanism [22]. In contrast, longer pulses (>10 ms)
have been shown to produce similar enhancement levels [37, 101,
168]. It is possible that with longer pulses destruction of the MBs in
the sonicated region [77] occurs during the first portion of the pulse
and thus the remainder of the pulse acts in the absence of MBs.
Microsecond length pulses and Doppler sequences have been
investigated to evaluate the safety of current transcranial diagnos-
tic imaging techniques. The safety of transcranial Doppler in both
healthy human volunteers [202] and patients with small vessel dis-
ease [112] has been investigated with no evidence of disruption.
Additionally, one study using Doppler-like parameters to disrupt
the BBB in rabbits, found the threshold for disruption to be higher
(MI between 3.5 and 5) than that employed for Doppler ultrasound
(MI <1.9 [202] and thus concluded that current Doppler techniques
are safe [99]. However, using a different MB contrast agent (Defin-
ity), more recent studies have found that very short pulses can dis-
rupt the BBB at more relevant pressures [22, 38, 169]. Additionally,
there has been one reported case of accidental disruption of the
BBB in a patient undergoing 300 kHz transcranial Doppler [189]. In
light of these studies it may be that the safety of current transcranial
imaging practices merits further study, especially when MBs are
used. However, as previously discussed (Section 2.7) transcranial
Doppler with MBs appears effective at improving stroke outcome.
In this thesis, we demonstrate that the BBB can be disrupted
with microsecond length pulses grouped together into bursts to
eliminate standing waves [168, 169]. Recently, the same technique
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has been shown to also result in a more homogenous distribution of
tracer in the tissue than long pulses [38]. Using closely timed short
pulses, the level of BBBD appears to increase with an increasing
number of pulses per burst [38, 169].
PRF has also been investigated in several studies. Goertz et al.,
demonstrated that with higher PRFs there is insufficient time be-
tween pulses for MBs to completely reperfuse the focal region [77],
resulting in inefficient treatments. However, in practice no statisti-
cally significant difference has been found between PRFs except for
very low PRFs [37, 149]. This may be due to high variability of the
data at each PRF examined [149]
The effects of MB type, dose and size have all been investi-
gated. In direct comparison, the pressure thresholds to induce dis-
ruption using Optison and Definity MBs were similar, but Opti-
son appeared to cause larger effects [147]. While McDannold et al.,
found no difference in effects with increasing MB dose [149], sev-
eral studies have documented increasing disruption and increasing
damage with higher MB doses [228, 248, 249, 260, 261]. One group
has used custom monodisperse microbubbles in several studies to
investigate the effects of microbubble size on various aspects of
BBBD [34, 198, 239]. The thresholds for disruption and cavitation
are higher for 1-2 µm MBs than larger 4-5 µm or 6-8 µm MBs at 1.5
MHz [34]. Similarily, for a given pressure, permeability [239] and
BBB healing time [198] both seem to decrease with smaller MBs.
As an alternative to MBs, one group used the photosensitizer
Rose Bengal as a mediating agent for BBBD [269]. An increase in
the number of vesicles was observed along with disruption of the
cytoplasmic membrane. However, no TJ abnormalities were seen.
In the absence of further studies, it is difficult to draw conclusions
from a single study. However, it may be that US combined with
a photosensitizer can open transcellular transport paths through
the BBB but does not have an effect on paracellular passage. The
photosensitizer may also have trapped gas bubbles which could
mediate the effects.
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3.5 MICROBUBBLE ACOUSTIC EMISSIONS DURING BBBD
The microbubble acoustic emissions generated during FUS BBBD
have been identified as a possible indicator of treatment outcome
[146]. BBBD has been found to occur without the presence of wide-
band emissions [146, 235]. It has been found that wideband emis-
sions are accompanied by an increase in the number of extravasated
RBCs [146] and, when the inertial cavitation dose (ICD) is high,
apoptosis [260].
Harmonic emissions have been proposed to assess treatment
progress. McDannold et al. found that when BBBD occurred it
was accompanied by an increase in harmonic emissions [146] and
first proposed the idea of BBB control based on acoustic emissions.
Tung et al. found that with their setup the fourth and fifth harmon-
ics were not present without MBs in circulation and thus proposed
that these harmonics may be a means for determining BBBD based
on acoustic emissions [235]. Although MB emissions during suc-
cessful treatments appear to differ from cases where the BBB re-
mains closed, active control of FUS BBBD based on acoustic emis-
sions has not previously been demonstrated. In this thesis the use
of MB emissions to safely control BBBD will be shown.
3.6 AGENT DELIVERY AND THERAPEUTIC EFFECTS
FUS has been used to deliver a number of agents cross the BBB
which do not normally permeate, and to increase delivery across
the BTB. Gadolinium-based contrast agents are most commonly
used for MRI monitored treatments and range in size from ap-
proximately 500-900 Da. Trypan blue (TB, 872.88 Da) and Evans
blue (EB, 960.81 Da) are commonly used to make the disrupted re-
gion easily visible in histology. Evans blue has a molecular weight
of 960.81 Da but has as high affinity for albumin and albumin-
bound EB is closer in size to 67 kDa [263]. Other tracers which
have been delivered across the BBB include Horseradish Peroxi-
dase (40 kDa) [100, 102, 206, 207], MION-47 (20 nm) [102], Alexa
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Fluoro 488 (10 kDa) [187], Texas Red tagged dextran (3-70 kDa)
[20, 33, 34, 37, 38, 40, 187], lanthanum cholride (139 Da) [207], 99mTc
diethylenetriamine pentaacetate (492 Da) [123,266], superparamag-
netic iron oxide (SPIO, 60 nm) [126, 131], and Mn2+ [88].
Anti-cancer agents have comprised the bulk of therapeutic
molecules delivered across the BBB and BTB. Kinoshita et al. de-
livered both Herceptin (≈150 kDa), an immunotherapy agent for
breast cancer, [114] and D4 receptor antibodies (≈150 kDa) [115]
to mice. In a rat model, Treat et al. delivered the chemotherapy
agent Doxorubicin (540 Da) [228]. In 2009, Mei et al. demonstrated
that FUS BBBD increased the amount of Methotrexate (545.44 Da)
delivered to the brain by 3.7 times what was achievable using an
intra-carotid injection [154]. These studies did not examine the
therapeutic effects of the delivered agents. Treat et al. first demon-
strated improved survival in a 9L gliosarcoma rat model following
FUS deliver of Doxil [227]. Free 1,3-bis(2-chloroethyl)-1-nitrosourea
(BCNU, 214 Da) [127] and BCNU immobilized on both a magnetic
nanoparticle (10-20 nm) for combined FUS and magnetic target-
ing [31] and immobalized on MBs [225] have all been delivered to
rat C6 glioma models with improved survival and growth suppres-
sion. When FUS was combined with magnetic targeting to deliver
BCNU [31] some doses resulted in a reduction of the tumor vol-
ume. In a similar manner, Epirubicin (543.5 Da) immobilized on
magnetic nanoparticles (6-12 nm) has been delivered to a rat tumor
model resulting in growth suppression [128]. Recently, delivery of
Herceptin to the brain in a rat metastatic breast cancer model has
shown improved outcome [173]. Another recent study presented
at conference demonstrated delivery of polyethylene glycol coated
gold nanoparticles (≈50 nm) to normal rat brain [60], which could
have potential applications in cancer treatment.
Apart from cancer studies, two studies have delivered anti-
amyloid-β antibodies (≈150 kDa) to Alzheimer’s model mice
[111, 188]. BAM-10 antibodies were found to reduce plaque vol-
ume and number in the targeted hemisphere relative to the control
side [111]. Recently, two groups have delivered stem cells to brain
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tissue [27,173]. One group has demonstrated the feasibility of gene
therapy in the brain by delivering brain-derived neurotrophic factor
pBDNF-EGFP-N1 using FUS and DNA loaded microbubbles [90]
The work that has been done to date has shown that a wide
number of agents can be delivered to the brain using this technique.
Given the robustness of MB mediated FUS BBBD, future studies
should focus on therapeutic effects of different agents rather than
on agent delivery alone.
3.7 LARGE ANIMAL STUDIES AND CLINICAL TRANSLA-
TION
BBBD has been demonstrated in pigs by several groups [91,125,259].
Two studies have used unfocused ultrasound to disrupt the BBB in
pigs [125, 259], one at very low frequency (28 kHz) where off tar-
get effects were observed due to reflections within the skull cav-
ity [125]. One study has demonstrated the use of a hemispherical
clinical prototype array (ExAblate4000) to induce BBBD in pigs [91].
Although large aperture arrays reduce the potential for reflections
in the skull cavity (Section 2.5), swine skulls are flat compared with
primate skulls and less well suited to hemispherical arrays.
Three non-human primate studies have been conducted to date.
A 2010 study on FUS-improved distribution of a tracer injected di-
rectly into the parenchyma is of limited interest due to the highly
invasive technique used [129]. In contrast, centers in Boston and
New York have both conducted transcranial BBBD investigations in
non-human primates [139,141,234]. In New York, a study on the use
of a single element transducer for transcranial BBBD has led to two
publications [139, 234]. The publications both report disruption of
the BBB in a primate. However, the study numbers are small, with
an even smaller number of successful openings, and at present no
histological data or cognitive test results have been presented. The
presented behavioral assessment has been minimal. An in silico
evaluation of the feasibility of using a single element transducer for
BBBD in humans and non-human primates concluded that such an
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approach was feasible [58]. However, the simulation results sug-
gested several problems with the approach including focal shifts
and the possibility of secondary foci [58].
The first investigations into transcranial BBBD in a primate were
initially presented at conference in 2010 [145]. This study uses
a clinical prototype phased array (ExAblate 4000, Insightec). The
completed investigation has recently been submitted for publica-
tion. Repeated disruption in multiple locations has been performed
in a number of monkeys. Cognitive testing shows excellent results
post-treatment [141]. This study is the first to demonstrate that this
procedure may be safe in humans, and represents a significant ad-
vancement towards clinical use.
While BBBD can be safe, inappropriate treatment parameters
will lead to tissue damage. Therefore, this thesis aims to minimize
sources of variability in treatments to improve treatment safety and
control. The novel pulse parameters and techniques developed will
be discussed in the following chapters.
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4 Materials and Methods
4.1 OVERVIEW
The methods used in Publications I-V can be grouped into four
categories: equipment, device fabrication, ex vivo/benchtop exper-
iments and in vivo protocols. These are outlined in the following
sections. The methods relating to the unpublished work on the de-
velopment of a clinical scale system, including simulations, device
fabrication and preliminary testing, are not described in this chap-
ter but can be found in Chapter 6.
Unless otherwise specified, data analysis for all publications
was performed in MATLAB (Mathworks, Inc., MA, USA). All acous-
tic measurements were performed in a rubber-lined tank filled with
degassed, de-ionized water.
4.2 EQUIPMENT
A detailed list of the equipment used in Publications I-V is pro-
vided in Table 4.1. Several different equipment models were used
in the publications primarily due to equipment availability. In the
following sections the equipment will be described in general terms
(e.g. function generator, RF power amplifier, etc.) excepting in-
stances where the experiments required features provided by spe-
cific equipment models. The exact equipment models used in each
study are detailed in the appended original publications.
Six different transducers were used in the studies. They are
summarized in Table 4.2. All transducers were matched to 50 Ω,
zero-phase at their driving frequency using external matching cir-
cuits in order to minimize reflected power. Transducer 5 was used
in both Publications II and III. After Publication II the transducer
was rematched to a lower frequency following cable repairs. Trans-
ducers 1-4 and 6 were PZT-4 ceramic, spherically focused, single
element, in-house constructed transducers. Transducer 6 (Publica-
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Table 4.1: List of equipment
Equipment
Category Description Model Manufacturer Studies
Function f. generator AFG3102 Tektronix TX, USA I, II
Generators f. generator 33220A Agilent CA, USA II, III, V
f. generator 295 Wavetek CA, USA I, II
Power pwr amp KAA2030 AR WA, USA I, II
Amplifiers pwr amp A-150 E&I CA, USA II
pwr amp NP2519 NP CA, USA II, III, V
Technology
pwr amp 240L ENI NY, USA I, II
Oscilloscopes\ Oscilloscope TDS3014B Tektronix TX, USA I
Scope Cards Oscilloscope WavePro leCroy NY, USA I, II
715Zi
14 bit PC ATS460 AlazarTech QC, CAN V
scope card
Hydrophones Needle 0.5 mm Precision Dorset, I
hydrophone diameter Acoustics, Ltd. UK
Fiber-optic 10 µm active Precision Dorset, I
hydrophone diameter Acoustics, Ltd. UK
Signal Signal DA1820A leCroy NY, USA I
Amplifiers amplifier
35 dB AU1583 MITEQ NY, USA I
preamplifier
Syringe Fringe-field Chemx Chemyx TX, USA III, V
pumps/motors compatible Nanojet Inc.
syringe pump
motor custom USR60-S3N Shinsei Tokyo, JPN III
syringe pump Corp.
MRIS 1.5 T MRI Signa 1.5 T GE WI, USA I,II, III, V
Healthcare
7 T small BioSpec Bruker MA, USA V
bore MRI 70/30 USR
Other Scanning PSV-400 Polytec Waldbronn I
Laser Scanning GER
Vibrometer Vibrometer
tion V) also had a center hole through which a hydrophone could
be mounted. Transducer 5 was a wideband composite spherically
focused 8 sector array (Imasonic, Inc, Voray sur Orgnon, France)
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Table 4.2: Transducer parameters
Tr
an
sd
uc
er
Ty
pe
f 0
(M
H
z)
A
pe
rt
ur
e
(c
m
)
F-
nu
m
be
r
Fa
br
ic
at
io
n
Pu
bl
ic
at
io
ns
1 single element 0.270 5 2 in-house I
2 single element 0.558 10 0.8 in-house I, II
3 single element 0.268 5 1 in-house II, IV
4 single element 0.548 5 1 in-house I, II
5a 8 sector array 1.503 10 0.8 Imasonicb II
1.18 III
6 single element 0.5515 7.5(2)c 0.8 in-house V
a Transducer 5 was rematched to 1.18 MHz after Publication II following
repairs to the cables
b Imasonic, Inc., Voray-sur-LOrgnon, France
c Spherically focused ring transducer, external diameter 7.5 cm,
internal diameter 2 cm
with integrated PZT hydrophone. Transducer 5 was driven with all
elements in phase as a single element transducer.
Transducers and hydrophones were calibrated by comparison
with factory calibrated fiber-optic hydrophones and the scanning
laser vibrometer [80]
4.3 DEVICE FABRICATION AND CHARACTERIZATION
The hydrophone described in the following sections was first pre-
sented in Publication I. The same device was later used in Publica-
tion V and in the unpublished work described in Chapter 6.
4.3.1 PVDF Hydrophone Fabrication
Polyvinydidene fluoride (PVDF) was chosen as the active mate-
rial in the fabricated hydrophone. PVDF has good sensitivity and
a wideband response, which make it well suited for use in hy-
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100 µm PVDF film
brass tubing (ground)
insulating layer
brass tubing (signal)
cork backed acrylic
transmit element
b) c) d)
a)
Figure 4.1: (a) Cut-section through hydrophone assembly and transmit element showing
construction; (b,c) 4.8 mm diameter hydrophone; (d) 2.5 mm diameter hydrophone potted
in a ring transmit element
drophones [15, 122, 181, 191, 201, 203]. The broadband response of
PVDF is ideal for monitoring acoustic emissions when complete
spectral information without receiver-induced limitations is required.
A broadband response also allows the receiver to be paired with
therapy transducers of different frequencies without requiring tun-
ing. A diagram of the hydrophone assembly is shown in Figure
4.1. The hydrophone was constructed from 110 µm thick PVDF
film with NiCu electrodes (700 ◦A Cu, 100 ◦A Ni, Measurement
Specialties, Inc. Hampton, VA, USA) and brass tubing. The PVDF
was stretched across the end of a length of brass tubing. A sec-
ond length of brass tubing with a flattened rim was pulled over
the first tube and used to clamp the PVDF in place. The brass-
tubes were separated by a thin insulating layer (Glad Press’n Seal
wrap). The mechanical clamping of the PVDF provided the electri-
cal connections, with the interior brass tubing providing the signal
connection and the exterior brass tubing connected to ground. The
designed hydrophone could be used independently (Fig. 4.1b,c) or
mounted within a ring transmit element (PZT-4, 10 mm external
diameter; 7 mm internal diameter; 6 mm height; f0 = 306 kHz) such
52 Dissertations in Forestry and Natural Sciences No 67
Materials and Methods
as those which make up the transcranial therapy array described by
Song and Hynynen [215] to form a combined transmit-receive pair
(Fig. 4.1a,d). When used as a transmit-receive pair, the PVDF hy-
drophone and ring transmit element were mounted on cork-backed
acrylic as shown in Figure 1. In Chapter 6 the integration of multi-
ple receivers into the therapy array described by [215], as well as the
testing of the resulting combined therapeutic and diagnostic array,
is described.
Two different sizes of receiver were constructed. The large re-
ceiver had an active element diameter of 4.76 mm, and the small
receiver had an active element diameter of 2.48 mm. Both sizes of
receiver were air-backed and contained a preamplifier within the
brass tubing in order to drive the long hydrophone cables needed
when experiments in an MRI scanner were conducted.
4.3.2 Preamplifier Design and Fabrication
A miniature preamplifier circuit was designed to be mounted in
the brass tubing of the hydrophone, immediately beside the PVDF
element. By placing the preamplifier in close proximity to the active
element the need for cabling between the receiver and preamplifier
was eliminated and the amount of noise introduced to the system
before the amplification stage was minimized. The brass tubing
acted as a Faraday cage to shield the preamplifier, further reducing
noise.
The preamplifier provided 20 dB of gain and the total circuit
board dimensions were 7.1 x 1.8 mm. In order to achieve such small
dimensions, a FHP3131 op-amp (Fairchild Semiconductor Corpora-
tion, California, USA) was used, which has component dimensions
of 1.45 x 1.00 x 0.55 mm. The op-amp was selected based on size
and on bandwidth (unity gain bandwidth of 70 MHz). The band-
width was important so as to avoid overly narrowing the band-
width of the receiver.
The preamplifier response was characterized over the frequency
range 0.1-5 MHz using a range of rail voltages and coaxial cable
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lengths. The characterizations were performed with and without
the PZT-4 ring element.
The suitability of the fabricated PVDF hydrophone for monitor-
ing transcranial therapy was evaluated by several means.
4.3.3 MRI Compatibility Testing
The receiver was first tested for MRI compatibility by imaging it in
a 1.5 T MRI. The MR testing was intended to test the functionality of
the hydrophone in the MRI while running an MRI scan and when
the MR scanner was idle. The testing also looked for any image
artifacts caused by the presence of the hydrophone in the magnet.
4.3.4 Sensitivity and SNR
The large size PVDF hydrophone was characterized and evaluated
by comparison with a 0.5 mm commercial needle hydrophone and
a PZT-4 element of similar size and shape. The sensitivity of the
constructed receiver and needle hydrophone were compared. Both
hydrophones were calibrated over the range 0.65-4.6 MHz against
an in-house constructed transducer which had previously been cal-
ibrated using a scanning laser vibrometer. The hydrophone paired
with the above described ring element was tested as a combined
transmit-receive element and compared with the needle hydrophone
in the same configuration by reflecting from an acrylic plate and cal-
culating the resulting SNR. Their relative performances without the
transmit element were also evaluated by placing the receivers in the
field and directly sonicating at 306 kHz with a ring element.
The constructed receiver was evaluated against a 5 cm diame-
ter focused PZT-4 element by examining their relative thresholds
for detection of different types of microbubble emissions. A thin-
walled tube (0.0152-0.0203 mm double-wall thickness, 2 mm diame-
ter medical balloon; Advanced Polymers, Inc., NH,USA) was filled
with diluted Definity microbubbles and sonicated using transducer
1. A 0.270 MHz PZT-4 element used as a passive cavitation de-
tector (PCD) was co-focused with the therapy transducer and the
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Figure 4.2: Experimental setup for PVDF receiver validation against a 5 cm diameter
spherically focused PZT-4 receiver (f-number 2).
constructed hydrophone was also directed at the tubing, at approx-
imately the same distance as the PCD. The experimental setup is
illustrated in Figure 4.2. The sonication pressures were increased
after each burst and the waveforms produced by each receiver were
recorded
4.3.5 Characterization of Hydrophone Angular Response
The angular response of the hydrophone was experimentally deter-
mined by measuring the signal strength detected from an emitting
ring transducer (10 mm external diameter; 7 mm internal diameter;
6 mm height; f0 = 306 kHz) over 180◦ of incidence in steps of 5◦.
The ring transducer was driven at both its fundamental frequency
and 3rd harmonic (approx. 830 kHz). The response was compared
with the analytical solution to the normalized far-field directivity
function for a circular piston [273]:
D(θ) =
2J1 [(2pia/λ) sin θ]
(2pia/λ) sin θ
(4.1)
where J1 is the first-order Bessel function of the first kind, a is
the radius of the receiver, and λ is the wavelength.
4.3.6 Transcranial Microbubble Detection
The ability of the PVDF hydrophone, acting in the transmit-receive
pair, to detect microbubble emissions both through a human skull
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Figure 4.3: Experimental setup for transcranial microbubble detection using the fabricated
PVDF receiver and 306 kHz ceramic ring transmit element. The combined pair is shown
as a cut section.
fragment and without an attenuator between the bubbles and re-
ceiver was examined. A thin walled tube (see Section 4.3.4) was
filled with normal saline and sonicated at 306 kHz (Fig. 4.3). The
resulting waveform was captured and used as a baseline reference.
This reference waveform was subtracted from subsequent sonica-
tions to eliminate the effects of reflections from the tube, tubing
mount and parts of the tank. The tube was then filled with diluted
Definity in 10:1, 25:1 and 100:1 ratios. Emitted waveforms from
the sonications at these dilutions were recorded. Pressure at the
tubing was measured for all sonications using the 0.5 mm needle
hydrophone.
In Publication I, in vivo testing of the PVDF hydrophone was
performed in 6 rats. These experiments are described in the follow-
ing sections.
4.4 EX VIVO/BENCHTOP MEASUREMENTS
All ex vivo and benchtop acoustic measurements were performed in
a rubber-lined tank filled with degassed, de-ionized water. All ex
vivo samples used in the measurements were degassed in a vacuum
jar for a minimum of 1 hour prior to the measurements in order to
remove any trapped gas.
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Figure 4.4: Experimental setup for acoustic field scans and insertion loss measurements
4.4.1 Acoustic field measurements and measurements of skull
insertion loss
Acoustic field measurements were performed using a 3-axis po-
sitioning system and either a needle or fiber-optic hydrophone.
Figure 4.4 shows an example configuration for benchtop measure-
ments. All experiments included a transmitting transducer mounted
in the tank. The transducer was typically driven with long bursts in
order to mimic conditions during in vivo sonications. The position
of the transducer focus in the transverse plane was determined by
performing raster scans with the needle or fiber-optic hydrophone
and sampling the acoustic field. Captured waveforms were trans-
ferred from the oscilloscope to a PC via a GPIB connection. Line
scans in the axial direction were then performed to obtain the axial
pressure profile.
The insertion losses of rodent skulls were measured by placing
formalin fixed skullcaps between the transducer and hydrophone
and comparing measured waveforms after skull insertion to the
magnitudes and profiles measured prior to skull insertion. For in-
sertion loss measurements the transducer focus was placed 5 mm
behind the skullcaps in order to simulate a mid-brain sonication.
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Figure 4.5: Experimental setup for measuring standing waves in ex vivo skull cavities
In Publication II the insertion losses of 11 rat skullcaps were mea-
sured post animal sacrifice in order to better estimate what the in
situ pressures had been during treatment. In Publication IV in-
sertion loss measurements were made through 22 rat skullcaps at
0.268, 0.841, 1.409, 1.972 and 2.53 MHz by driving transducer 3 at
its various harmonics. Further, measurements were made through
1 mouse and 1 rabbit skullcap at 2.53 MHz and compared with the
measurements through rat skull. The insertion losses at the various
frequencies through rat skull were compared with the animal mass
to determine if a relationship could be established. Measurements
were averaged over four locations in each skull.
4.4.2 Standing Wave Measurements in Rat Brain
To measure standing waves in rat brain, a transducer was mounted
in a large tank and the transducer focus was localized as described
above. The experimental setup for measuring standing waves is
illustrated in Figure 4.5.
Small holes (<1mm) were drilled through the skullbase of in-
tact formalin-fixed ex vivo rat skulls, stopping at the top of the
brain. The skulls were mounted in front of the transducer and
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Figure 4.6: Modified waveform for eliminating standing waves. (Top) Function generator
output; (Bottom) Transducer output as measured by the fiber-optic hydrophone at the focus.
positioned at the focus using a 3-axis stage. Degassed water was
flushed through the drilled hole using a syringe in order to remove
any air bubbles. A fiber-optic hydrophone was used to measure the
pressure profile in the brain. The axial pressure profile in the skull
cavity was measured by scanning from the skullbase to the top of
the brain.
Several techniques were used to examine and attempt to min-
imize the standing wave effects. The effect of frequency was ex-
amined by driving transducer 3 at 0.268, 0.841, 1.409, 1.972 and
2.503 MHz. Sweep frequencies were examined with transducers
3 and 5 by sweeping with 100 kHz, 200 kHz and 300 kHz band-
widths about 0.841 and 1.503 MHz. Sweeps occurred over a 1 ms
period and corresponded to average time rates of change of 100-
300 MHz/s. The sweep period was limited by the function genera-
tor used.
To eliminate the standing waves a modified waveform (Fig. 4.6)
was used in which the function generator sent a single excitation
cycle to the transducer with a high repetition rate, repeated over a
10 ms burst. The repetition rate was determined by how long the
transducer rang following an excitation cycle. A duty cycle of 50%
was desired during the 10 ms bursts. Transducer 3 rang for 40 µs
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Table 4.3: Description and dosages of injectables for in vivo studies
Description Dosage Manufacturer
Ketamine 40-50 mg/kg
Xylazine 10 mg/kg
Definity 0.02 ml/kg Lantheus Medical Imaging MA, USA
Microbubbles
Ominscan MRI 0.2 ml/kg GE Healthcare WI, USA
contrast agent
following an excitation at 268 kHz and 20 µs following excitation
at 841 kHz. Therefore, to achieve a 50% duty cycle, delays between
excitation cycles of 80 and 40 µs were used at 268 and 841 kHz
respectively. Transducer 5 was a wideband composite for which a
5 µs delay at 1.503 MHz was required to achieve a 50% duty cycle.
The modified pulse was generated using two function generators,
one to provide trigger pulses at appropriate intervals and one to
generate the driving pulses. Hydrophone scans in the rat brain
that had been performed with long pulses were repeated when the
modified pulse was employed. This technique was referred to as
’Short Bursts’ (SB) in Publication II.
4.5 IN VIVO EXPERIMENT PROTOCOLS
All animal experiments were approved by the institutional animal
care committee. An overview of the general method for perform-
ing MRI-guided FUS disruption of the BBB in a rat model and the
variations used in Publications I-III, and V are described in the fol-
lowing sections. Table 4.3 summarizes injectables delivered during
the in vivo studies. All transducers were calibrated prior to the in
vivo experiments, either using the scanning laser vibrometer or the
calibrated fiber-optic hydrophone system as described in the pre-
vious sections. The distribution of animals and the experimental
parameters are summarized in Table 4.4. Unless otherwise speci-
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Table 4.4: Experimental parameters for the in vivo experiments
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a Continuous wave excitation; b Short burst excitation (no standing waves)
c Pressures modulated during the sonications based on acoustic emissions.
Pressures achieved are described in the following chapter.
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Figure 4.7: General experimental setup for in vivo experiments
fied, animals were sacrificed approximately 2 hours post-treatment.
4.5.1 Animal Preparation
Male rats (Wistar or Sprague Dawley strains) ranging in mass from
approximately 200 to 600 g were used in all in vivo studies. The ani-
mals were first anesthetized with isofluorane gas and then removed
from the isofluorane a minimum of 10 minutes prior to treatment,
following administration of injectable anesthetics (40 to 50 mg/kg
ketamine, 10 mg/kg xylazine) via intramuscular or intraperitoneal
injection. The hair on their heads was removed using an electric
razor followed by depilatory cream. Animals were positioned on
the top plate of a three-axis MRI compatible positioning system
(operationally similar to that described by Chopra et al. [41]) with
their heads coupled to the ultrasound transducer via a water bath
(Fig. 4.7).
4.5.2 Generation and Monitoring of the Ultrasound
Transducers were driven using a function generator and RF power
amplifier. In Publications I and V, the acoustic emissions during the
sonications were detected using the PVDF hydrophone described
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Figure 4.8: Hydrophone configurations. Transducer 4 (left) had a PVDF hydrophone
mounted to the side; Transducer 5 (middle) had an integrated hydrophone; Transducer 6
(right) had a center hole where a PVDF hydrophone could be mounted.
above. In Publication I the hydrophone was placed beside the trans-
ducer directed at the focus as shown in Figure 4.8. Transducer 6 had
a center hole which allowed the hydrophone to be co-axially aligned
with the transducer (Publication V). Transducer 5 had an integrated
PZT hydrophone with a center frequency of 750 kHz which was
used in to monitor emissions (Publication II). Waveforms were cap-
tured by either a LeCroy WavePro 715Zi oscilloscope, or an ATS460
14 bit PC scope card.
4.5.3 Sonications: General
Definity contrast agent (0.2 ml/kg) was injected into a tail vein
catheter simultaneously with the start of all sonications. A min-
imum of 5 minutes was allowed between sonications in order to
allow the microbubbles to clear from the system. Sonications were
performed in up to 4 locations in each brain at 0.5 MHz (transduc-
ers 4 and 6) and up to 8 locations in each brain at 1.2 and 1.5 MHz
(transducer 5), bilaterally. Based on measurements through ex vivo
rat skullcaps, ultrasound transmission through the skull was esti-
mated to be approximately 73% at 0.5 MHz, 56% at 1.2 MHz and
50% at 1.5 MHz. Using these values, in situ treatment pressures
could be estimated assuming a further transmission through 5 mm
of brain tissue (a mid-brain sonication) and taking the attenuation
coefficient in brain tissue to be 5 Np/m/MHz [101].
Three different types of sonications were used in the studies and
are described below.
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4.5.4 Sonications using Continuous Wave Bursts
In the simplest case, sonications consisted of 10 ms long bursts,
during which a CW signal was applied. Bursts were repeated at
a frequency of 1 Hz for the duration of the sonication (typically
2 minutes). Applied pressure varied between sonications but re-
mained constant for the duration of the sonication. This type of
sonication was employed in I and II.
In Publication I, six rats were treated at four locations in each
brain to determine if the PVDF hydrophone could detect relevant
acoustic emissions during BBBD (transducer 4, 558 kHz). Two lo-
cations received two sonications each. The second sonication was
performed after the first did not result in opening. A total of 26 son-
ications were performed at estimated in situ pressures ranging from
0.14-0.33 MPa. In Publication II, data from 47 rats treated at four
locations in each brain was analyzed. Rats were treated at 558 kHz
(transducer 4) with in situ pressures ranging from 0.2-0.45 MPa. The
purpose of these experiments was to examine the patterns of con-
trast enhancement along the ultrasound path following disruption
for indicators of standing waves.
4.5.5 Sonications using the Short Burst Technique for the Elim-
ination of Standing Waves
To investigate BBBD in the absence of standing waves the modified
pulse described in Section 4.4.2 was used in II and III to disrupt the
BBB in rats. Sonications consisted of 10 ms long bursts comprised
of the closely-timed single excitation cycles. Sonications were 2 or
5 minutes in length.
In Publication II, 11 rats were sonicated at 1.503 MHz (trans-
ducer 5) in a total of 8 locations in each rat. In one hemisphere
four locations were treated as controls and sonicated with contin-
uous wave bursts. The contralateral hemisphere was sonicated in
four locations roughly symmetric about the midline with the con-
trol locations so that paired analysis could later be performed on
the data. These locations were sonicated using SB excitation and a
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Figure 4.9: Timing diagram for short burst (SB) parameter study (Publication III). The
time between bursts, burst length and delay between cycles were all variable.
50% duty cycle (approximately 5 µs between the start of excitation
cycles). Bursts were repeated at 1 Hz for a total of 2 minutes. Five
animals were treated with estimated in situ pressures ranging from
0.36-0.83 MPa to determine if the pressure threshold for disruption
was the same using continuous wave bursts and short bursts. The
remaining 6 animals received sonications at either 0.58 or 0.71 MPa
to compare the enhancement levels between the two burst types.
In Publication III, 28 rats were used to examine the influence of
different sonication parameters and the injection means on BBBD in
the absence of standing waves. The timing diagram for this experi-
ment is shown in Figure 4.9. The animals were treated at 1.18 MHz
(transducer 5) in 8 locations in each animal and each sonication was
either 2 min or 5 mins in length. As in II, one side received four
sonications and was used as a control. In the control case the delay
between cycles was 6 µs and the burst PRF was 1 Hz. Delays of 60,
300 and 600 µs were investigated, as was the case of a single ex-
citation pulse delivered every second. A second group of animals
was used to investigate the effects of burst PRF while keeping the
delay between cycles constant at 6 µs. A syringe pump was used to
deliver the microbubble contrast agent in a slow infusion and PRFs
of 0.2, 1 and 2 Hz were investigated. Finally, bolus microbubble
injections and microbubble infusions were examined over different
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injection timings (15 s bolus, 1 min infusion, 4.5 min infusion, 2 x
30 s infusions).
4.5.6 Acoustically Controlled Sonications
In Publication V real-time acoustic feedback control was used. The
implemented algorithm utilized the presence of ultraharmonics to
modulate the in situ acoustic pressure real-time. Ultraharmonics
were used as the control parameter because, unlike harmonics, they
can only arise from bubble activity [161]. The subharmonic was
also considered however, the subharmonic band was found to be
more susceptible to spurious noise from the MRI scanner which
might result in erroneous measurements. This noise is associated
with this particular experimental set up and is not a generally truth.
The sub-harmonic signal may work as well as the ultraharmonics
however, we could not investigate this with the current setup.
The 4.8 mm diameter PVDF hydrophone described above was
mounted in the center of transducer 6 (551.5 kHz). Sonications con-
sisted of 10 ms CW bursts repeated at a 2 Hz PRF. Microbubbles
were delivered in a 1 minute slow bolus via a syringe pump in or-
der to prolong the bolus peak. A flowchart outlining the control
logic is shown in Figure 4.10. Waveforms were captured during
each burst using the ATS460 PC scope card. The Fast Fourier trans-
form of the signal was obtained in real time and the 1.5 f0 and 2.5 f0
ultraharmonics were quantified by integrating over the spectrum
around those frequencies (±180 Hz). The presence of ultraharmon-
ics was evaluated by comparing the resulting values to those ob-
tained at time t = 0 s (no microbubble in circulation). The applied
pressure increased after each burst from a starting in situ pressure
of 0.09 MPa until the detection of ultraharmonics. Once ultrahar-
monics were detected the pressure would scale to a pre-determined
target level, some percentage of the pressure required to induce ul-
traharmonics, for the remainder of the sonication. If ultraharmonics
were detected a second time another drop would occur.
Twenty-seven animals received sonications in 2 or 4 locations
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Figure 4.10: Control logic for acoustic emissions based controller.
each. Thirteen animals received sonications at different target lev-
els: 75%, 50%, 25% and 0% of the pressure required to induce ul-
traharmonics. In the case of a 0% target level, the sonication would
terminate upon first detection of ultraharmonic emissions. The re-
maining fourteen animals received 2 or 4 sonications at the 50%
target level. Twelve of these animals were survived for follow-up at
8 days via high-field MRI and then were sacrificed.
4.5.7 MRI Imaging and Analysis
Baseline T1w and T2w images were acquired on a 1.5 T MRI and
used to select the sonication targets. MRI parameters are summa-
rized in Table 4.5. Contrast enhanced (Omniscan, 0.2 ml/kg) T1w
images were used to confirm BBBD. Post-treatment T2w images
were examined for high signal indicating edema.
Twelve animals in Publication V were imaged 8 days post-
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Table 4.5: MRI Parameters
T1w (1.5 T) T2w (1.5 T) T2w (7 T) T2*w (7 T)
Sequence Type FSE FSE RARE MGE (8 echoes)
TE 10 ms 60.6 ms 36.9 ms -
TR 500 ms 2000 ms 3000 ms 1500 ms
First Echo Time - - - 4 ms
Echo Spacing - - - 5 ms
ETL/RARE factor 4 4 8 -
FOV 6 cm x 6 cm 6 cm x 6 cm 3 cm x 3 cm 3 cm x 3 cm
Matrix 128 x 128 128 x 128 150 x 150 150 x 150
Slice Thickness 1mm 1mm 0.5 mm 0.5 mm
treatment on a 7T MRI. T2 and T2* weighted images were obtained
and examined for any indicators of treatment-induced damage. T2
weighted images were examined for indicator of edema, while T2*
images were used to evaluate the presence of hemorrhage [130,249]
4.5.8 Histology
Histological analysis was performed on some rat brains post-
treatment in Publications III-V. Following animal sacrifice, brains
and skullcaps were extracted and fixed in 10% buffered formalin.
The brains were then embedded in paraffin wax and serially sec-
tioned in the axial plane in 5 µm sections. Hematoxylin and eosin
staining was performed at 300 µm levels throughout. The stained
slides were examined at the sonication sites for three characteristics
to evaluate the level of tissue damage: red blood cell extravasations,
vessel rupture and changes to the tissue matrix. Vacuolated tissue
would be one example of an identifiable change in the tissue matrix.
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5 Review on the Results of
Publications I-V
5.1 PUBLICATION I
In Publication I an MRI-compatible wideband PVDF hydrophone
was designed and constructed. The hydrophone was tested alone
and when paired with a 306 kHz ring transmit element (external
diameter 1 cm), and compared with a focused PZT-4 ceramic re-
ceiver (5 cm aperture) and a 0.5 mm needle hydrophone. The PVDF
receiver was used to monitor BBBD in rats at 558 kHz and with es-
timated in situ pressures ranging from 0.14-0.33 MPa.
5.1.1 Hydrophone Characterization
The PVDF hydrophone was found to be MRI compatible in a 1.5 T
MRI. Acoustic waveforms could easily be captured with the MRI
idle. Some noise was added when the MR scanner was imaging,
but the spectral information from the signal was still discernable.
The artifact induced by the receiver was small and, as in practice
the receiver was over several centimeters away from the imaging
planes, this did not impact the quality of MR images obtained.
Both the large and small size PVDF hydrophones were found
to have higher sensitivity than the commercial needle hydrophone.
The sensitivities of the PVDF receivers and the needle hydrophone
at 306 kHz and 830 kHz are summarized in Table 5.1. The 4.8 mm
diameter PZT-4 receiver was more sensitive than the PVDF over
some frequency bands but, in contrast with the PVDF, it did not
have a flat response over the frequency range of interest (Fig. 5.1).
The large aperture (5 cm, 0.270 MHz) focused ceramic receiver was
much more sensitive than the 4.8 mm PVDF receiver. However, the
thresholds for detection of different microbubble emissions (har-
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Table 5.1: Comparison of the PVDF receiver and 0.5 mm commercial needle hydrophone
characteristics.
Sensitivity (306 kHz) Sensitivity (830 kHz) SNR
Large PVDF 1.62 ± 0.09 V/MPa 1.38 ± 0.16 V/MPa 61.1 ± 4.9
Receiver
Small PVDF 0.88 ± 0.03 V/MPa 1.12 ± 0.09 V/MPa -
Receiver
0.5 mm Needle 0.24 ± 0.01 V/MPa 0.34 ± 0.03 V/MPa 90.8 ± 6.2
Hydrophone
0 1 2 3 4 5
0
5
10
S
en
si
ti
vi
ty
(V
/
M
P
a
)
Frequency (MHz)
PZT-4 Receiver (4.8 mm diam.)
PVDF Receiver (4.8 mm diam.)
PVDF Receiver (2.48 mm diam.)
Needle Hydrophone (0.5 mm diam.)
Figure 5.1: Sensitivity of the 4.8 mm PZT-4 and 4.8 mm PVDF receivers over the fre-
quency range 0.3-4.6 MHz, and sensitivity of the 2.48 mm PVDF receiver and 0.5 mm
needle hydrophone at 0.306 and 0.841 MHz.
monics, subharmonics and wideband emissions) were the same
(Fig. 5.2).
The measured directivity of the large PVDF receiver matched
well to the theoretical directivity. At 830 kHz the -3 dB point of the
receiver signal strength was approximately ± 10◦. The -3 dB point
of the small receiver was calculated to be approximately double that
of the large receiver (± 21◦). At a distance of 15 cm from the receiver
this corresponds to a field of view ± 26 mm from the acoustic axis
for the large receiver and ± 58 mm for the small receiver.
Microbubble emissions were detected by the PVDF receiver
when sonicating a thin-walled tube both directly and indirectly.
Pressure at the tubing was measured to be approximately 46 kPa
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Figure 5.3: Waveform (a) and spectrum (b) detected following a direct sonication of a thin-
walled tube filled with microbubbles. Waveform (c) and spectrum (d) detected following
a sonication of a thin-walled tube filled with microbubbles through a fragment of human
skull.
when directly sonicating the tubing, and 0.22 kPa when sonicating
through a fragment of human skull. At these pressures harmonic
emissions were detected from the direct sonication but not from the
through skull sonication (Fig. 5.3). However, linear emissions were
detected and the addition of a second transmit element to increase
the pressure at the tubing resulted in harmonic emissions detected
through skull. At Definity concentrations of 10:1 and 25:1 the de-
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Table 5.2: Results of in vivo monitoring of acoustic emissions during BBBD with a
wideband PVDF hydrophone from Publication I. The total number of sonications at each
pressure is indicated in brackets.
Pressure (MPa) Disruption Edema Sub/Ultra- Wideband
harmonics Emissions
0.14 0 (2) 0 (2) 0 (2) 0 (2)
0.16 3 (4) 0 (4) 0 (4) 0 (4)
0.18 4 (4) 0 (4) 0 (4) 0 (4)
0.22 3 (3) 0 (3) 0 (3) 0 (3)
0.20 4 (4) 4 (4) 4 (4) 0 (4)
0.24 4 (4) 4 (4) 3 (4) 0 (4)
0.27 4 (4) 4 (4) 4 (4) 4 (4)
0.33 1 (1) 1 (1) 1 (1) 1 (1)
All 23 (26) 13 (26) 12 (26) 5 (26)
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Figure 5.4: Spectra from waveforms captured during BBBD showing different types of de-
tected emissions. (a) The fundamental frequency, harmonics, and sub and ultraharmonics
are visible. (b) Wideband emissions are also seen.
tected pressures were approximately 5% and 2.5%, respectively, of
the pressures at the tubing.
5.1.2 Monitoring of Acoustic Emissions during BBBD
The results of the in vivo experiments are summarized in Table 5.2.
Disruption of the BBB was achieved following 23 of 26 sonications.
The three sonications which did not yield disruption occurred at
the lowest pressures (0.14 and 0.16 MPa). Three different types of
acoustic emissions were detected during BBBD: harmonics, sub and
ultraharmonics, and broadband noise (Fig. 5.4). The different emis-
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Figure 5.5: CE-T1w (a) and corresponding T2w (b) images post FUS showing T1w en-
hancement indicating disruption at 3 of 4 sonication locations and T2w enhancement
indicating edema at 2 locations. (c-f) Corresponding spectral data from bursts captured
at each sonication location. Sonication pressures were 0.15 MPa (location 1), 0.18 MPa
(location 2), 0.22 MPa (location 3) and 0.27 MPa (location 4).
sion types were detected at increasing pressure intervals. Inertial
cavitation, as identified by broadband noise, was detected during
five sonications at 0.27 and 0.34 MPa estimated peak-negative pres-
sure. All sonications during which subharmonics or ultraharmonics
were detected resulted in T2w edema (Fig. 5.5). Only one sonication
produced edema without detection of sub or ultraharmonics.
From the results of Publication I it was determined that the fab-
ricated PVDF hydrophones were suitable devices for monitoring
transcranial therapy. Further, it was supposed that the presence of
sub and ultraharmonics may indicate that the safety limit for in situ
pressure has been reached. This was later investigated in Publica-
tion V, the results of which are described later in this chapter.
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Figure 5.6: Standing waves in the brain measured at insonation frequencies of 0.268,
0.841, 1.409, 1.972 and 2.530 MHz. The profile through the focus is measured before
(thick line) and after insertion of the skull sample (thin line) and the data are normalized
to the maximum pressure before skull insertion. Bottom right shows the standing waves
profiles at 268 kHz and 1.972 MHz normalized to maximum amplitude.
5.2 PUBLICATION II
In Publication II, the effects of standing waves during transcranial
BBBD were investigated. Axial pressure profiles in rat brain were
measured in ex vivo skulls and several techniques were investigated
to reduce the standing waves. In vivo, disruption of the BBB was
investigated in rats with standing wave conditions, as well as when
using a modified pulse to create a purely travelling wave field.
5.2.1 Standing Waves in the Skull Cavity
Standing waves were identified in the skull cavity at all frequencies
examined. Figure 5.6 shows the axial pressure profiles through the
transducer focus in water and inside the rat skull at 0.268, 0.841,
1.409, 1.972 and 2.530 MHz. The spacing of the oscillations of the
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Table 5.3: Results of the ex vivo standing wave analysis from Publication II
Burst Type Frequency (MHz) Standing Waves Max./Min.
(mean ± S.D.)
CWa 0.268 Y 1.46 ± 0.19
CW 0.841 Y 1.88 ± 0.46
CW 1.409 Y 1.49 ± 0.18
CW 1.972 Y 1.32 ± 0.15
CW 2.530 Y 1.45 ± 0.25
CW 1.503c Y 1.25 ± 0.21
200 kHz sweep 0.841 Y 1.73 ± 0.54
200 kHz sweep 1.503c Y 1.32 ± 0.13
SBb 0.268 Y 1.45 ± 0.35
SB 0.841 Y 1.38
SB 1.503c N -
a Continuous wave excitation;b Short burst excitation;
c Wideband composite transducer
pressure profiles within the skull cavity was λ/2, which is consis-
tent with standing waves. The ratio of the maximum and mini-
mum of the standing waves averaged over the profiles are summa-
rized in Table 5.3. Sweep frequencies were unsuccessful at reducing
standing wave amplitude or the spatial involvement of the stand-
ing waves within the skull cavity. At 0.268 and 0.841 MHz the
use of the short burst excitation pulse did not reduce the standing
wave amplitude, as can be seen in Table 5.3, but spatially restricted
the waves to close to the skull base (Fig. 5.7). When SB excitation
was implemented with the wideband composite transducer (trans-
ducer 5) at 1.503 kHz, standing waves were eliminated (Fig. 5.7).
SB excitation was tested in three locations over two skulls and was
successful in eliminating standing waves in all instances. However,
with short burst excitation, standing wave conditions could still be
forced when the transducer focus was pushed very close to the skull
base.
Standing waves were also found to be highly dependent on son-
ication location. Investigation of pressure profiles over several loca-
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Figure 5.7: Profile through the focus at 268 kHz (top left) reduced duty cycle, and at 841
kHz (top right). Profile through the focus 1.503 MHz using continuous wave (bottom
left) and single cycle pulses at 50% duty cycle (bottom right). Thick lines indicate CW
excitation, without skull.
tions in two skulls found that the amplitude and spatial distribution
of the waves varied substantially from location to location. While
some sonications produced the largest amplitude standing waves
near the reflective skull base and top of the skull, others resulted
in more uniform standing waves throughout the entire skull cavity.
From these results it was determined that accurate estimation of
in situ pressures, without complex simulations, is impossible when
long pulses are used in rodent skulls as the distribution of standing
waves cannot be predicted.
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1 mm
Figure 5.8: Contrast-enhanced T1 weighted images of coronal sections of two rat brains
after microbubble-mediated blood-brain barrier disruption at 558 kHz. Enhancement in-
dicating BBB opening is visible at the half-wavelength spacing characteristic of standing
waves. The animals are supine in these images, and the transducer is located below the
head.
Table 5.4: Summary of sonication results at 1.503 MHz from Publication II
CWa Sonications SBb Sonications
Study No. Animals Opening Edema Opening Edema
threshold 5 11(19) 6(19) 9(19) 2(19)
determination
enhancement 6 22(22) 19(22) 22 (22) 9(22)
comparison
a Continuous wave excitation;b Short burst excitation;
5.2.2 BBBD in the Absence of Standing Waves
Of the 47 animals sonicated at 558 kHz, 13 animals showed banded
patterns of enhancement in at least one sonication location which
were confirmed as standing wave effects by the consistent half-
wavelength center-to-center spacing of the bands (Fig. 5.8). Over
half the animals showed some enhancement patterns that could
possibly have resulted from standing waves although standing
wave contribution could not be confirmed.
The BBB was successfully disrupted using short burst excite-
ment at 1.503 MHz (Fig. 5.9). Table 5.4 summarizes the results of
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Figure 5.9: (Left) Contrast-enhanced T1w image of a rat brain normalized to baseline
images showing enhancement after sonication using 10 ms bursts consisting of continuous
wave excitation (left side) and 10 ms and 50 ms bursts consisting of closely timed short
bursts (right side). The arrows indicate sonication locations. (Right) Summary of opening
of the BBB using continuous wave excitation and SB excitation. The number of locations
where opening was detected for CW and SB bursts, and the total number of locations
sonicated at each pressure is shown.
the sonications at 1.503 MHz. The threshold for disruption was
found to be approximately the same for continuous wave excitation
(11/19 disruptions) and short burst excitation (9/19 disruptions) at
approximately 0.47 MPa (Fig. 5.9). In the six animals used to com-
pare enhancement mean, continuous wave sonications were found
to produce statistically higher enhancement levels than the short
burst sonications (two-tailed t-test, p=0.00001 at 0.58 MPa, p=0.0005
at 0.71 MPa). However, there were a greater number of sonications
using CW excitation which resulted in T2w edema (19/22) versus
short burst excitation (9/22).
The approximate skull losses at each sonication location were
measured through the ex vivo skullcaps and used to calculate es-
timated in situ pressures post-treatment. The enhancement values
for the rats treated at 0.58 and 0.71 MPa nominal in situ pressures
are plotted in Figure 5.10 versus updated pressure estimates based
on hydrophone measurements at each sonication location. A weak
linear trend can be seen in the SB data, whereas the CW data shows
no correlation with pressure.
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Figure 5.10: Enhancement as a function of peak negative pressure for continuous wave
excitation (top) and burst excitation (bottom). The dashed line represents the reported
values for the mean enhancement and approximate threshold during BBB opening in rabbit
brain through a craniotomy window at 1.63 MHz with a sonication duration of 20 s [101].
The dotted line represents the reported values for the mean enhancement and approximate
threshold during BBB opening in rabbit brain through a craniotomy window at 2.04 MHz
with a sonication duration of 20 s [148].
The results of Publication II show that when continuous wave
insonations are used in the brain, pressure cannot be accurately es-
timated and results will be highly variable. Standing waves are not
required to induce BBBD and the use of short burst excitation can
induce more predictable levels of disruption. Variability in skull
losses in the ex vivo skulls was observed. Inter and intra-animal
variability in skull insertion loss were later investigated in Publica-
tion VI.
5.3 PUBLICATION III
The robustness of the short bursts excitation pulse and the effects of
acoustic parameters on BBBD in a purely travelling wave field were
investigated in Publication III. The BBB was disrupted in 28 rats
at 1.18 MHz using a wideband composite transducer and a control
case of a 10 ms bursts at a 1 Hz PRF and a 6 µs delay between cycles
in the burst. The effects of the delay between cycles in a burst, burst
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Figure 5.11: (Left) contrast enhanced T1w image of a rat brain after BBBD in eight loca-
tions. Delay between cycles (1) 300 µs,(2) 600 µs, (3) 1 s, (4) 60 µs, (5-8) 6 µs; (Middle)
Baseline T2w image of the same rat brain; (Right) Post-treatment T2w image of the same
rat brain showing enhancement indicating edema at eight sonicated locations.
PRF, and the microbubble injection type and rate were examined.
5.3.1 Influence of Acoustic Parameters on BBBD in the Absence
of Standing Waves
Figure 5.11 shows post-treatment contrast enhanced T1w and T2w
images of a rat brain which has been treated with different delays
between cycles within each burst. As the delay between cycles in a
burst increased, the mean enhancement seen at the sonication loca-
tions decreased (Fig. 5.12). However, disruption was still observed
using a single excitation cycle, approximately a 3 µs pulse, repeated
at 1 Hz. No statistical difference was found between enhancement
means of the 60 µs delay case and the control case of a 6 µs de-
lay (paired, two-tailed t-test, p=0.145). However, for the larger time
delays between cycles (300 µs, 600 µs and 1 s) statistically lower en-
hancements were observed (p=0.033, p=0.016 and p=0.018, respec-
tively). A semi-log relationship was found between the number of
cycles in a burst and the enhancement mean (Fig. 5.12). The con-
trol case produced the most instances of edema (17/40), however
all time delays produced T2w edema in at least one case (2/10 at 60
µs, 4/10 at 300 µs, 3/10 at 600 µs, 1/10 at 1 s). Further, no param-
eters resulted in enhancement levels greater that 30% without also
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Figure 5.13: (Left) Paired mean enhancement using different burst PRFs. The control
case of a 1-Hz PRF is shown in white. (Right) Paired mean enhancement using different
infusion types. The control case of a 15-s bolus delivered using an infusion pump is shown
in white. Error bars indicate the standard error.
causing T2w edema.
Burst PRF had some impact on enhancement when a long in-
fusion of microbubbles was used (Fig. 5.13). A 0.2 Hz PRF was
found to produce a significantly lower enhancement mean than a
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1 Hz PRF (p=0.04). However, at 2 Hz only a small increase in en-
hancement mean over the control case was observed, and without
statistical significance (p=0.4).
5.3.2 Influence of Microbubble Injection Means on BBBD in the
Absence of Standing Waves
Bolus injections produced much higher average enhancement than
long infusions of more than 4 minutes (43.4 ± 4.7% vs. 16.0 ±
1.6%). However, the long infusion resulted in more consistent en-
hancement. Shorter infusions (1 minute; 2 x 30 s bolus at t=0 s, t=2.5
min) produced no significant difference in enhancement mean over
the control case of a 15 s automated bolus (p=0.88 and p=0.66 re-
spectively) (Fig. 5.13).
The results of Publication III suggest that the BBB can be dis-
rupted with far shorter bursts than previously believed at reason-
able pressures. These shorter bursts did not increase treatment
safety since edema occurred at the same T1w enhancement level
as with the control case. However, the use of very short bursts may
be helpful in increasing throughput as many treatment locations
could be treated within the delay between bursts. As in Publica-
tion II, some inter-animal variability in enhancement mean was still
observed despite the absence of standing waves.
5.4 PUBLICATION IV
Despite the use of purely travelling wave fields to disrupt the BBB
in Publications II and III, inter-animal variability in mean post-FUS
contrast enhancement was still observed. Publication IV describes
an ex vivo study in which variations in skull bone thickness and
animal mass were examined as possible sources of error when esti-
mating in situ pressures. Measurements of ultrasound transmission
through mouse, rat and rabbit skulls were performed at frequen-
cies ranging from 0.268-2.53 MHz. Measurements were made at
four locations through each of 22 formalin-fixed rat skullcaps us-
ing a fiber-optic hydrophone. Additional measurements were made
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Figure 5.14: (Top left) Average skull thickness in 22 rat skull caps as a function of animal
mass. A line of best fit and its equation are shown. (Middle and bottom left, right)
Ultrasound transmission through skull versus rat mass for 0.268 MHz, 0.841 MHz, 1.409
MHz, 1.972 MHz and 2.530 MHz. A line of best fit and its equation are shown for each
plot. Error bars indicate the standard error.
through 1 mouse and 1 rabbit skullcap. The thicknesses of the rat
skullcaps were measured using digital calipers.
5.4.1 The Effect of Skull Bone Thickness on Ultrasound Trans-
mission
Parietal bone thickness was found to increase proportionally with
mass with an approximate increase of 0.015 mm per gram of an-
imal mass (Fig. 5.14). The mean skull thickness measured across
all rat skull was 0.71 ± 0.03 mm. At 0.268 and 0.841 MHz, ultra-
sound transmission and animal mass were found to be inversely
proportional (Fig. 5.14). At higher frequencies the data were more
scattered and larger standard errors were observed on intra-animal
measurements. The linear relationship between mass and attenu-
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Table 5.5: Mean (mean ± S.E.) transmission through all rat skulls (Publication IV)
Frequency(MHz) Average Transmission (%)
0.268 91.2 ± 1.7
0.841 66.6 ± 1.7
1.409 60.5 ± 2.0
1.972 63.8 ± 2.7
2.530 56.7 ± 2.8
Table 5.6: Mean (mean ± S.D.), maximum and minimum values for 10 transmission
measurements in one skull. Values at four different measurement locations for f0 and 9 f0
are presented.
0.268 MHz 2.53 MHz
Location Mean Max. Min. Mean Max. Min.
1 0.83 ± 0.02 0.86 0.80 0.54 ± 0.06 0.62 0.44
2 0.79 ± 0.02 0.83 0.76 0.56 ± 0.08 0.72 0.42
3 0.82 ± 0.02 0.85 0.80 0.72 ± 0.08 0.85 0.64
4 0.79 ± 0.01 0.81 0.76 0.76 ± 0.03 0.80 0.71
ation began to breakdown at 1.409 MHz and did not exist at all
at 1.972 and 2.53 MHz (Fig. 5.14). The average transmission val-
ues at each frequency are summarized in Table 5.5. Figure 5.15
shows the transverse pressure profiles measured through rat skull
at the five frequencies. When compared with the profiles in wa-
ter alone, it can be seen that distortion caused by the insertion of
the skull increases with increasing frequency. This can also be seen
in the accompanying phase plots (Fig. 5.15). At the highest fre-
quency (2.53 MHz) the distortion effects were found to be highly
location dependent. Different locations in the same skull, as well
as in different skulls of similar mass produced varying amounts of
distortion. At the lowest frequency the distortion effects were of
similar amounts across the different measurements. Repeatability
measurements (Table 5.6) found the measurements at 0.268 MHz to
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Figure 5.15: Contour plot showing (left to right) the normalized pressure profile of trans-
ducer focus in the transverse plane in water; normalized pressure profile of transducer fo-
cus in the transverse plane in water through a rat skullcap; corresponding absolute phase
difference maps plotted from 0 to pi. (Top to bottom) Pressure and phase plots at 0.268,
0.841, 1.409, 1.972 and 2.503 MHz. Contours are shown at 10% intervals.
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Figure 5.16: Contour plot showing (left to right) the normalized pressure profile of trans-
ducer focus in the transverse plane in water; normalized pressure profile of transducer
focus in the transverse plane in water through a skullcap; corresponding absolute phase
difference maps plotted from 0 to pi. (Top to bottom) Pressure and phase plots through
mouse skull, rat skull and rabbit skull. Contours are shown at 10% intervals.
be highly repeatable, while those at 2.53 MHz were much less so.
Figure 5.16 shows the transverse pressure profiles at 2.53 MHz
measure through the three different species (mouse, rat, rabbit).
The mouse skull produced minimal distortion over all locations
measured, while the rabbit skull produced the greatest distortions
and the highest signal losses. The corresponding phase plots also
show an increase in distortion with the larger animals.
The results of Publication IV suggest that animal mass at sub-
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megahertz frequencies can be used to better predict in situ pres-
sures. However, in order to produce highly repeatable in vivo re-
sults, a greater level of control may be required.
5.5 PUBLICATION V
In Publication V, an acoustic emissions-based controller was pre-
sented for active control of BBBD. Disruption was performed in two
or four locations in each of 27 rats. The controller would increase
the pressure following each burst until detection of ultraharmonic
emissions, at which point the pressure would decrease for the re-
mained of the sonication to a target percentage of the pressure re-
quired to induce ultraharmonics, or the sonication would terminate
(0% target level). Target levels of 0%, 25%, 50% and 75% of the pres-
sure required to induce ultraharmonics were investigated. Twelve
animals were survived to 8-day follow-up by high-field MRI.
5.5.1 BBBD using an Acoustic Emissions Based Controller
The controller successfully disrupted the BBB for all target levels
investigated (Fig. 5.17). In the acute animals, the 0% and 25% levels
showed the lowest disruption rate (approximately 75% of sonica-
tions), while at the 50% level 10/11 sonications results in disrup-
tion Fig. 5.18). At the 75% disruption level all sonications produced
disruption. However, over 50% of the sonications also resulted in
T2w edema. In the acute animals, none of the sonications at 0, 25
or 50% resulted in T2w edema.
The mean enhancement increased with target level (Fig. 5.18).
The mean enhancement was found to be statistically different at the
0% and 25% target levels than at the 75% target level (two-tailed,
t-test, p=0.005 and p=0.048 respectively). While no statistical sig-
nificance was found between the 0% and 50% target levels (p=0.1),
significance may have been found had a larger number of animals
been used.
Of the survival animals, four instances of T2w edema were
observed approximately 20 minutes post-treatment (Fig. 5.19).
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Figure 5.17: CE-T1 and T2 weighted MRI images of a rat brain after sonication. Locations
1 through 4 correspond to sonication at 0%, 25%, 75% and 50% respectively. Sagittal
images through locations 3 and 4 are shown. In the axial images the sonication direction
is into the page. In the sagittal images the sonication direction is indicated by the white
arrows.
However, at 8-day follow up no abnormalities were detected by
high-field MRI on both T2w and T2*w scans.
Histological analysis of the acute specimens found normal tis-
sue matrix and some quantity of extravasated red blood cells in the
animals treated at 0, 25 and 50% target levels (Fig. 5.20). At the 75%
target level, larger amounts of extravastations were observed. Two
sonications at 75% produced large regions of highly vacuolated tis-
sue with a sharply delineated margin (Fig. 5.20), consistent with is-
chemic necrosis reported by Vykhodtseva et al. [242]. These sonica-
tions also produced particularly high T2w signal with a sharp mar-
gin following treatment. Histological analysis was performed on
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Figure 5.18: (Top) Percentage of sonications at each target level resulting in opening (dark
bars) and in edema (light bars). The total number of sonications performed at each target
level is indicated above the bars. (Bottom) Mean enhancement as a function of targeted
pressure level (% of the pressure required to achieve detectable ultraharmonic emissions).
Error bars indicate the standard error.
1.5 T, 20 min
post-treatment
7T, 8 days
post-treatment
Figure 5.19: (Left) T2w image obtained approximately 20 minutes post-treatment on a
1.5 T magnet showing high signal at one sonication location; (Right) T2w image from the
same animal obtained 8 days post-treatment showing no indicators of edema.
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Figure 5.20: (a-c) Histology slices from acute specimens. 2x (a) and 5 x (b) images of a
75% target level sonication location showing a bleached area of the tissue in the sonication
region, highly vacuolated tissue and large amounts of extravasations; (c) Normal tissue
matrix with some extravasations visible at a sonication location treated at a 50% target
level; (d) Histology slices from a specimen sacrificed 8 days post-treatment showing normal
tissue matrix without extravasations.
all brains from survival animals which had shown T2w edema im-
mediately post-treatment but not at 8-day follow up. These brains
showed normal tissue matrix and no red blood cell extravasations
were observed (Fig. 5.20). Additional immunohistochemistry was
performed on 2 brains, staining for neuronal nuclei with NeuN an-
tibodies. The cell counts in the sonicated regions of these brains
showed no significant difference (p = 0.66, 2-tailed paired t-test) to
cell numbers in the immediately adjacent, unsonicated tissue. The
sonicated regions had an average of 99.7 ± 9.7 % of the cells in the
unsonicated region, with a minimum of 90 cells counted per region.
Publication V demonstrated that FUS induced BBBD can be
safely performed using feedback control based on microbubble
emissions.
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6 Development of a Clinical
Scale System
The work in Publications I-V centered on better predicting in situ
pressure fields and their effects. While MRI is a useful platform for
targeting and assessing treatment outcome, it has yet to be proven
as a suitable modality for real-time assessment of microbubble in-
teractions with applied pressure fields. Thus, as used in Publica-
tions I and V, ultrasound monitoring may be a more appropriate
means for real-time capture and control of acoustic emissions. In I
and V a single planar receiver was used to record emissions. While
a single receiver represents the simplest case and may be appropri-
ate for proof of concept, such a configuration cannot localize the
emission sources. Alternatively, an array of receivers would allow
for microbubble activity to be spatially mapped. Not only could
this establish if cavitation events are occurring near the intended
focus, but it could also be used to spatially map the field and estab-
lish if field irregularities, such as standing waves, arise.
Passive beamforming is an established technique for mapping
acoustic sources [79,165,166,197]. By incorporating phase informa-
tion, rather than just the waveform envelope, passive beamforming
can localize multiple sources at once, regardless of burst length.
Image resolution then depends on array aperture, and large aper-
ture arrays are most ideal. As transcranial ultrasound therapy al-
ready employs large aperture arrays in order to reduce skull heating
and standing wave effects, the task of integrating a receiver array is
somewhat simplified.
In Publication I, an MRI-compatible polyvinylidene fluoride
(PVDF) receiver was developed and tested in combination with
a laterally coupled ring element, described in [215] to establish
the feasibility of the receiver for monitoring transcranial therapy.
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This chapter describes the expansion of that concept to a three-
dimensional receiver array fully integrated with an existing 1372
element therapy array [215]. The passive beamforming capabilities
of the array are examined and initial results are presented.
6.1 MATERIALS AND METHODS
6.1.1 Array Design and Fabrication
A receiver array was designed to be integrated with an existing
transcranial therapy array [215]. The therapy array consisted of
1372 cylindrical elements (inner diameter = 7 mm, outer diameter
= 10 mm, height = 6 mm) set within a 30 cm diameter hemispherical
dome and driven at a fundamental frequency of 306 kHz.
Publication I examined the feasibility of designing and im-
plementing a combined transmit/receive element by mounting a
PVDF receiver within one of the cylindrical transmit elements. Re-
ceiver array designs were evaluated by simulating arrays with dif-
ferent numbers of elements and different configurations. The cen-
ter of each transmit element was considered a possible receiver
location. Intensity maps were generated from simulated point
sources using a Time Exposure Acoustics beamforming algorithm
[79, 165, 166]. The formulation which removes the ’DC bias’ associ-
ated with time averaging of intensity values was employed [166]. In
these simulations, the emitted signal was first propagated to the re-
ceivers, and then the individual receiver signals were beamformed
to produce the intensity maps. The receivers were approximated
as point receivers. This was deemed acceptable for point sources
located near the geometric centre of the array. Simulations were
performed in MATLAB (Mathworks, MA, USA) for configurations
of 32, 64, 128, 256, 512 and 1372 receiver elements.
Due to acquisition hardware limitations an initial design of 32
receivers was chosen for implementation. Receivers had an active
element diameter of 2.48 mm and were constructed as described
in Section 4.3.1. Unlike previous generations of the receiver, the
20dB preamplifiers for each receiver were not mounted within the
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Figure 6.1: (Clockwise from top left) 1372 transmit element transcranial therapy dome
with 32 integrated PVDF receivers; Diagram of receiver layout within the dome; Pream-
plifier circuit boards; Close-up view of receivers potted in the transmit elements.
receiver casing but in banks of preamplifiers mounted on the rim of
the dome array (Fig. 6.1). This change was necessary to further re-
duce the receiver dimensions so that no new holes had to be drilled
into the therapy array to install them. The receivers were pot-
ted in the transmit elements using reusable adhesive (TAC’N STIK
Reusable Adhesive, Ross Glue). Testing showed that this method of
mounting the receivers did not impact transducer output. Prior to
installation, the sensitivity of each receiver at 306 kHz and 840 kHz
was measured.
After installation, receiver locations were determined using a
1.5 mm diameter, 765 kHz transducer. The hemispherical array was
placed in a rubber lined tank filled with degassed, de-ionized water.
The 765 kHz transducer was placed near the geometric center of the
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1.5 mm diameter
765 kHz source
Transmit ElementReceive Element
Figure 6.2: Experimental setup: receiver localization
array and driven using a function generator (AFG3102, Tektronix,
TX, USA) (Fig. 6.2). The signals at each receiver were acquired using
a 32 channel pulser/receiver (OPEN System, LeCoeur Electronique,
Chuelles, France). Using a 3-axis positioning system, the transducer
was moved to several locations in the dome and the emitted signals
were acquired. The positions of the receivers were then triangulated
in MATLAB using the acquired signals.
Using the measured receiver positions, the beamforming capa-
bilities of the implemented design were examined. Simulations of
point sources emitting at the fundamental frequency, 2nd and 3rd
harmonic of the transmit array (approximately 306 kHz, 612 kHz
and 918 kHz) were performed. At each frequency the imaging res-
olution of the array was examined by simulating multiple point
sources at 2 mm, 4 mm and 8 mm spacing.
6.1.2 Experimental Measurements
The 1.5 mm diameter 765 kHz transducer was placed at the centre
of the array. A 200 cycle (approximately 260 µs) burst was emitted,
driven by a function generator and captured by the receiver array.
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The signals were beamformed to produce an intensity map of the
source, which was compared with simulation results.
A formalin fixed human skull cap was then inserted between
the array and the 765 kHz transducer (Fig. 6.3). The skull cap
was degassed in de-ionized water for 3 hours prior to the exper-
iment. Approximate phase lags through the skull were determined
by comparison of the waveforms from a single sonication with the
765 kHz transducer before and after skull insertion. The calculated
phase delays from the 765 kHz transducer through the skull were
used to correct for aberrations through the skull when beamform-
ing. Several sonications with the 765 kHz transducer were captured
and the resulting intensity maps with and without phase correction
were examined. These were compared with sonications from the
765 kHz transducer before insertion of the skull.
To examine the ability of the array to map cavitation signals,
a tube containing a 100:1 solution of degassed water and Definity
contrast agent (Lantheus Medical Imaging, MA, USA) was placed
at the transmit array focus (Fig. 6.3). The pressures achieved at the
tubing were measured with a calibrated 0.2 mm needle hydrophone
(Precision Acoustics, Ltd., Dorset, UK). A 50 cycle, 306 kHz burst
was emitted by the therapy array, which was driven using an in-
house designed multi-channel amplifier [213]. The receiver sig-
nals were collected with the OPEN system acquisition hardware
and transferred to a PC. This was repeated for two Definity filled
tubes separated by 4 mm in the transverse direction. The data were
beamformed in MATLAB. A digital notch filter was used to remove
the fundamental frequency from the receiver signals prior to beam-
forming. This was done to eliminate confounding reflection signals
from parts of the apparatus.
6.2 RESULTS
As expected, side-lobe intensity decreased with the number of sim-
ulated receivers. Figure 6.4 shows intensity maps of a 918 kHz
source in the transverse plane for 32, 64, 128 and 256 receiver con-
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Figure 6.3: Experimental setups for (top) transcranial narrowband source measurements,
(bottom) cavitation measurements
figurations. The decrease in side-lobe intensity followed an expo-
nential decay (Fig. 6.5). At 256 and 512 receivers, the side-lobe
intensity was only slightly higher than that of the fully populated
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Figure 6.4: Normalized intensity maps of a simulated 918 kHz point source for 32, 64,
128 and 256 receive elements. Contours are drawn at 5% intervals
array. However, with only 32-receivers the side-lobe intensity was
over four times that of the fully populated array. The available ac-
quisition hardware limited the implemented array to an initial 32
receivers and the remaining simulations were performed with the
implemented 32 receiver configuration.
Simulations of two point sources at various separations (Fig. 6.6)
found that the lateral resolution of the array decreased from 4.2 mm
for 306 kHz point sources, to 2.1 and 1.4 mm for 612 and 918 kHz
point sources respectively. Therefore, if passive beamforming were
performed at the therapy array’s higher harmonics a minimum res-
olution of 2.1 mm could be expected. Multifrequency and broad-
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Figure 6.5: Normalized side lobe intensity versus number of receive elements
band signals were not simulated. However, in practice multifre-
quency content reduces interference between multiple sources [79].
Due to the hemispherical nature of the array, axial resolution was
approximately half that of the lateral direction.
When mapping the 765 kHz narrowband source, experimen-
tal results matched well with a simulated 765 kHz point source
(Fig. 6.7). In practice, sidelobes were higher than in the simulation,
although were found in the same locations. The simulations did
not account for reflections from the mounting apparatus and con-
sidered the receivers and the source as points. These differences
may explain some of the variations between the experimental and
simulation results.
Figure 6.8 shows intensity maps generated from the 765 kHz
transducer directly, through-skull without phase correction, and
through-skull with hydrophone based phase correction. With hy-
drophone based correction, the map was similar to the direct soni-
cation case, but with larger side-lobes and some amount of distor-
tion. Without phase-correction no information could be obtained
from the intensity map.
The cavitation measurements also matched well with the sim-
ulated results (Figs. 6.9, 6.10). The intensity maps of the tubes
produced elongated sources compared with the simulated point
sources. The direction of the elongation was along the tubing, as
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Figure 6.6: Intensity maps of simulated point sources. Source configuration and intensity
maps for sources emitting at 306, 612 and 918 kHz (top to bottom) with 0, 2, 4 and 8 mm
(left to right) spacing are shown.
was expected. Beamforming the higher harmonics, the two tubes
were easily discernable at 4 mm spacing (Fig. 6.10). As with the
case of the narrowband source, the experimental side-lobes were
larger than the simulated side-lobes. Additionally, the use of multi-
ple sources increased the side-lobes. This suggests that in practice a
greater number of elements will be required in order to accurately
map cavitation activity during BBBD.
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Figure 6.7: (Left) Source configuration and intensity map for a simulated 765 kHz point
source. (Right) Source configuration and intensity map generated from experimental data
from a 1.5 mm diameter, 765 kHz source.
6.3 DISCUSSION
Initial results from transcranial measurements suggest that cavita-
tion mapping through-skull will be feasible when the receiver array
is expanded to a larger size. By expanding to a larger number, the
side-lobes will be decreased, improving image quality. The effects
of reflections from the skull and the superposition of side-lobes
from multiple sources will thus be reduced with a larger number
of elements. Additionally, with 256 elements, sidelobes should be
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Figure 6.8: Intensity maps generated from (left) a 1.5 mm diameter, 765 kHz source, (cen-
ter) a 1.5 mm diameter, 765 kHz source sonicating through-skull without phase correction,
(right) a 1.5 mm diameter, 765 kHz source sonicating through-skull with hydrophone based
phase correction.
sufficiently suppressed to image ± 12 cm from the geometric focus,
which would allow for imaging of the skull bone and cavitation
events occurring at the bone/tissue interfaces.
In the absence of the skull, cavitation from Definity microbub-
bles was successfully mapped when the bubbles were subjected to
realistic pressures (0.1-0.25 MPa) for BBBD at 306 kHz. Further,
the detected harmonic signals had sufficient amplitude that even if
attenuation through the skull reduced the amplitude by half they
would be clearly visible above the noise floor. However, signals
registered when sonicating microbubbles through the human skull
were complicated by reflections from the skull and harmonics gen-
erated in the skull. In Publication I these reflections were removed
by subtracting a reference signal with a tube filled with water from
that when the microbubbles were sonicated. With the larger scale
system, limitations of the driving and acquisition hardware made
it difficult to ensure that the trigger delay was consistent between
sonications. Without the skull, application of a digital notch fil-
ter to remove the fundamental was an appropriate replacement for
the reference subtraction. However, with the addition of skull re-
flections this proved inadequate. This problem may be solved in the
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Figure 6.9: (Left) Source configuration and intensity map for a simulated 612 kHz point
source. (Right) Source configuration and intensity map generated from experimental data
from a 200 µm diameter thin-walled tube filled with 100:1 solution of Definity contrast
agent, sonicated at 306 kHz, approx. 0.19 MPa PNP. The intensity map was generated
using the harmonic emissions.[approx 0.19 MPa]
next generation of the array by implementing hardware notch filters
so that the fundamental frequency is removed prior to digitization,
allowing more bits for the low amplitude bubble emissions.
The hydrophone-based phase correction used in the skull mea-
surements provides a simple method for benchtop correction. In
practice, a CT based correction method [43] could be used to pro-
vide a clinically usable correction. This would allow the phases to
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Figure 6.10: (Left) Source configuration and intensity map for two simulated 612 kHz
point source with 4 mm spacing. (Right) Source configuration and intensity map gener-
ated from experimental data from two 200 µm diameter thin-walled tubes filled with 100:1
solution of Definity contrast agent, sonicated at 306 kHz, approx. 0.23 MPa PNP, and
spaced approximately 4 mm apart. The intensity map was generated using the harmonic
emissions. [approx 0.23 MPa]
be adjusted for each point in the reconstruction, rather than using
one set of phase correction values as in this study.
The initial array demonstrates that the large aperture arrays
used in transcranial therapy are ideal for passive beamforming ap-
plications. At 918 kHz, 1.4 mm lateral resolution can be obtained
despite the use of very long pulses and a very sparse array. The
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next generation array will have 256 elements and improved driv-
ing/acquisition hardware. Using the passive beamforming tech-
nique, the use of such a large number of elements will also suppress
reflection effects. Large signals which correspond to reflections will
be cancelled out and focal gains on real cavitation events will im-
prove. Such a combined therapy and diagnostic array could also
have applications in ultrasound angiography. The images produced
in this study were all generated from single sonications, without av-
eraging. In imaging applications, where averaging could be used,
image quality could be greatly improved.
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The aim of this work was to identify sources of variability in tran-
scranial FUS induced BBBD and to develop novel techniques for
reducing the variability in treatments and improving safety. The
major findings of the work can be broadly grouped into four cate-
gories: the elimination of standing waves and BBBD with very short
pulses (Publications II and III), the establishment of a relationship
between insertion loss of rat skull and animal mass (Publication IV),
the development of an acoustic-emissions based controller (Publica-
tions I and V), and development of a clinical scale system (unpub-
lished work). These findings are discussed in the following sections.
The limitations of the present work are discussed at the end of this
chapter.
7.1 ELIMINATION OF STANDING WAVES IN THE SKULL
CAVITY
Standing waves greatly increase in situ pressures in the brain over
the estimated pressures, particularly near bone interfaces, which al-
ready represent regions of higher energy absorption. Apart from
the unpredictable pressure magnitudes associated with standing
waves, they also lead to unpredictable distributions. The irregular-
ity of the skull bone means that the angle of reflection of the sound
can vary quite a bit. As a result, reflections and standing waves can
result in unwanted high pressures elsewhere in the brain. While
grating lobes are a safety concern in any treatment, they are of
particular concern in brain tissue where treatment mistakes could
result in brain damage or death. In the human skull cavity, when
large aperture arrays are used, standing wave effects are greatly
reduced [216]. However, in small animal models, where most re-
search is being conducted, standing waves must be acknowledged
in order to produce clinically translatable results. Publication II
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suggests that most current work being done to investigate transcra-
nial BBBD and optimize parameters may not have correctly esti-
mated in situ pressures. However, the results of Publication II did
establish that BBBD can occur in the absence of standing waves
and that previous work conducted has validity. The implications
of this result for the advancement of clinical FUS-induced BBBD
are great. Were standing waves required to induce BBBD, it would
likely never advance into clinical practice as the safety concerns
with inducing standing waves in the brain are too great. In fur-
ther investigating BBBD in the absence of standing waves (Publica-
tion III), it was determined that the BBB could be disrupted using
very short bursts (<3 µs in length). Short pulses have been used
to disrupt the BBB at high frequencies (5.7 MHz) at high bubble
concentrations (20-120 times the recommended clinical dose) [22].
However, previous work at 1.5 MHz using 10 µs bursts found that
the BBB could not be disrupted below 6.3 MPa, and sonications at
these pressures had associated tissue damage [99]. In that study,
a high PRF was used, and there may have been insufficient time
between bursts to allow replenishment of the MBs [77], resulting in
an inefficient sonication. In addition, Optison microbubbles were
used, while Definity bubbles were used in Publication III and [22],
and differences in the bubble properties may account for these suc-
cesses in disrupting the BBB with short sonations. Publication III
confirmed that the BBB can be disrupted with short pulses at safe
pressures, and demonstrated that this can be achieved at clinically
relevant frequencies and below the maximum recommended mi-
crobubble dose for humans. The major advantage of this finding
is the potential to reduce overall treatment time by scanning the
transducer focus through a larger number of sonication locations
within the 1 second repetition time. This could greatly increase
experimental through-put or reduce clinical treatment times.
It was hypothesized that the use of the short burst technique
and the use of very short pulses would improve treatment safety.
In addition to safety concerns arising from the unpredictable nature
of standing waves, standing waves and long pulses may reduce the
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threshold for inertial cavitation. Kerr et al., [113] suggested that
in a standing wave field cavitation thresholds may be reduced, as
cavitation nuclei become trapped in the field. In addition, Atchley
et al., [10], demonstrated that the threshold for inertial cavitation
in water decreases with an increasing number of cycles. In Publi-
cation II, the smaller number of instances of T2w edema observed
using the short burst technique compared with continuous wave
bursts, and the failure to detect inertial cavitation during any of
the short burst sonications suggested that some safety benefits may
arise from the use of shorter sonations. However, in Publication III
it was found that while fewer cases of T2w edema were observed
using the shortest pulses, the mean enhancement was also lower.
In Publication III, all sonications which resulted in mean enhance-
ments of 30% or more also showed T2w edema. Therefore, while
a lower number of cycles may reduce the inertial cavitation thresh-
old, shorter bursts do not increase the level of CE-T1w enhance-
ment that can be achieved without T2w edema and do not increase
safety in this regard. However, as discussed, the new techniques
employed in Publications II and III do provide an increase in safety
by generating a more predictable in situ field. The other parameters
investigated in Publication III resulted in fewer findings. For the
most part, few statistical differences were found between investi-
gated parameters and the control sonications. One possible reason
that significant differences were not observed with many of the pa-
rameters is that there remained variability in the control sonications
due to sources of error that were not accounted for. These may in-
clude differences in skull thickness and vasculature in the different
regions targeted as well as many other possible sources.
7.2 INSERTION LOSS OF RAT SKULL WITH ANIMAL MASS
While the results of Publication IV have no direct clinical implica-
tions, they highlight a flaw in a common assumption in pre-clinical
studies - that the losses through rodent skulls at a particular fre-
quency can be estimated from a mean value. Publication IV demon-
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strated that this was certainly false in rat models, which are a com-
mon model for transcranial BBBD investigations. At lower frequen-
cies, it appears that the losses can be more accurately estimated
when animal mass is considered. At the higher frequencies (>1.5
MHz) the inter and intra-animal variability was much higher and
no trend with mass could be established. The linear relationship
between mass and transmission was best represented in the sub-
megahertz data, and appears to breakdown somewhere between
1.4 and 2 MHz. From this it would be reasonable to conclude that
frequencies above approximately 1.5 MHz should be avoided in rat
models, unless other techniques can be used to predict pressures.
Pre-treatment MR-ARFI has been shown to correlate well with
BBB disruption in rats [120]. This could provide one means of esti-
mating in situ pressures when higher frequencies are investigated.
However, Publication IV also saw distortion effects at higher fre-
quencies, which cannot be corrected using a single element trans-
ducer. Mouse models may be better at higher frequencies as they
distort the sound less that rat models. However, it may be possible
to investigate higher frequencies in rat models if a phased array is
used and aberrations are corrected for.
The most important conclusion that can be drawn from Pub-
lication IV is that the variations in skull bone thickness and cur-
vature between rats is sufficient to introduce impactful errors into
pre-clinical studies. These errors can be minimized though appro-
priate frequency selection and consideration of animal mass. Con-
veniently, the frequency range over which the relationship between
transmission and mass is linear is the clinically relevant frequency
range. As Publications I-III used mean transmission values in most
calculations, some variability in the results from these studies may
be attributable to animal size. Particularly, the results of Publication
IV may explain the remaining variability in enhancement after the
elimination of standing waves in II and III.
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7.3 ACOUSTIC EMISSIONS BASED CONTROL OF BBBD
Publications II-IV all investigated error in estimated in situ pres-
sures under the assumption that the in situ peak negative pressure
is the controlling factor for the degree of disruption. However, from
II-IV it can be seen that in situ pressures can be difficult to correctly
estimate. Further, it may be that the in situ pressure is less im-
portant that the microbubble behavior, if disruption is dependent
on microbubble stimulation. In Publication I, sub and/or ultrahar-
monics were detected during all but one sonication which resulted
in T2w edema. Although the number of animals and thorough-
ness of the in vivo work in Publication I was too small to make
conclusions, the possibility that sub or ultraharmonics might mark
the upper safety limit for treatments existed. Publication V tested
this hypothesis, while also demonstrating the feasibility of real-time
acoustic emissions based control of BBBD, the possibility of which
was first proposed by McDannold et al. [146].
The results of Publication V demonstrate that pressures to in-
duce ultraharmonic emissions can be reached briefly during sonica-
tions without gross tissue damage, but maintaining pressure levels
near those required to induce ultraharmonics may be unsafe. The
proposed technique of increasing pressure until ultraharmonics are
detected and then decreasing treatment pressures to an established
safe fraction of this maximum pressure was consistent in disrupt-
ing the BBB, and 50% of the pressure to induce ultraharmonics was
found to be an appropriate target level to safely perform disruption.
At the 75% target level large amounts of tissue matrix damage were
observed but without apparent vessel rupture. In future applica-
tions, higher target levels may be useful for creating non-thermal
lesions. Others have shown that microbubbles can be used to in-
duce apoptosis and lesions in the brain at much lower power levels
than required for thermal lesioning [153,242,243]. One major bene-
fit of such an approach is that it would allow treatment of near-skull
regions of the brain which cannot be treated with thermal ablation
due to skull heating concerns.
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The BBB controller eliminated the requirement for precise calcu-
lation of in situ pressure by controlling the bubble emissions. While
consistent disruption was obtained, enhancement varied. One pos-
sible reason for this would be the open loop behavior of the imple-
mented algorithm after detected ultraharmonics. The microbubble
population might change, with the bubbles shrinking or growing
over time in circulation, during the course of the treatment. It has
also been shown that vasoconstriction and vasodilation can both
occur during sonications with microbubbles [33, 186, 187]. Thus the
vessel diameter and the perfusion rate may change during treat-
ment, which would influence bubble behavior. Currently there is no
way to update the program behavior to account for these changes.
Future work could investigate a fully closed-loop control program
that also examines harmonic emissions and broadband noise. The
current program also used continuous wave bursts which would
induce standing waves. However, unlike the CW sonications in
paper II which did not use a controller, the sonications in Publica-
tion V produced more results which were consistently within the
safe treatment range. In the future the short burst technique may
be incorporated with the controller routine. However, it was ex-
cluded from the first generation algorithm for simplicity. The pro-
posed controller and the implications of the results are still valid as
a standing wave field presents the most challenging conditions to
control and the algorithm was robust enough to be effective.
The control algorithm from Publication V has the most potential
for clinical impact. Currently no real-time monitoring technique ex-
ists for non-thermal FUS brain treatments. By demonstrating that
these treatments can be controlled real-time, Publication V has ad-
dressed one of the major safety concerns hindering the translation
of FUS induced BBBD to clinical use. Hopefully this will spur con-
tinued research into these control techniques and the development
of more complex and robust algorithms.
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7.4 CLINICAL TRANSLATION
The aim of the ongoing work developing a clinical scale system,
described in Chapter 6, is to apply the advances in knowledge from
the Publications into an improved device. Existing hemispherical
prototypes developed by other groups and the ExAblate 3000/4000
systems (Insightec) can be configured to detect acoustic emissions,
but at the expense of some of the transmit elements. The receiver ar-
ray developed here could be expanded to up to 1372 elements while
maintaining a fully populated transmit array. The limiting factor is
the acquisition hardware which could be developed to support such
a large array. The use of dedicated PVDF receive elements also has
advantages over ceramics or composites, which could be used as
either transmit or receive elements, in that the wideband response
of the PVDF allows for the acquisition of data with more complete
spectral information.
Initial results suggest that passive cavitation mapping and pas-
sive imaging will be feasible with the combined array. The fact that
microbubbles circulate everywhere and interact with the acoustic
field outside the focus is a safety concern. However, with expan-
sion of the receiver array to 256 elements, a sufficiently large field
of view should be achievable in order to image the entire brain
volume. Then, during treatments, cavitation could be mapped
throughout the entire field. Significant standing wave fields, if they
were to arise, could be detected, increasing safety. The acoustic con-
trol algorithm presented in Publication V would be easy to imple-
ment, and the use of an array would allow localization of emission
sources.
Initially, it would be feasible to use the receive elements in the
array to monitor the spectral data real-time during treatments. The
necessary spectral information could be processed by the controller
while storing the full waveforms in memory for post-processing.
Post-treatment the waveforms could be beamformed to localize the
bubble activity and gain insight into the treatments. This could
potentially provide useful information about the mechanisms of
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BBBD. Comparing the cavitation maps with post-treatment CE-T1w
and T2w images in pre-clinical models could provide more insight
into the relationship between different emission types and the de-
gree of disruption or damage. Investigations comparing cavitation
maps during disruption and MRI images may also establish if treat-
ment outcome can be assessed without MRI and will be an area of
future study.
A longer term goal would be to perform the passive beamform-
ing in real-time during treatment. For this to be achievable, it re-
quires not only significant computer processing power, but also an
optimized reconstruction algorithm. Thus, one area for future work
is to develop an algorithm that will allow reconstruction of the skull
cavity volume at a sufficiently fast rate. The multichannel signal
capture hardware is also an area of ongoing work such that data
from a larger number of channels (up to 256) can be acquired.
7.5 STUDY LIMITATIONS
There are several study limitation in addition to those already dis-
cussed. These are described at length in the publications, which are
appended. The majority of the studies were performed at a limited
number of frequencies with one type of transducer configuration.
Since it was impossible to investigate all potentially relevant fre-
quencies and parameters, study parameters were selected based on
what seemed most clinically relevant from the literature.
7.6 FUTURE CLINICAL POTENTIAL
FUS BBBD is on the verge of clinical investigation. Its potential
as a clinical tool is exciting. The method opens up the possibility
of treatments for a large number of conditions which have previ-
ously had no, or poor, treatment options. Initial clinical treatments
will most likely proceed under MRI guidance. However, the need
for MRI guidance will restrict access to the technology even within
the developed world. As such, once clinical investigations begin,
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there will be an even greater need for research into this field. De-
velopment of portable and inexpensive guidance and monitoring
techniques will be essential for FUS BBBD to achieve its full po-
tential. Future work should focus on solving these engineering
problems and, if successful, there is the potential to revolutionize
neuro-medicine and to have a truely global impact.
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8 Conclusion
This thesis examined several sources of variabiliy in current focused
ultrasound disruption of the Blood-Brain barrier techniques. The
objectives were both to improve preclinical research practices, as
well as develop techniques which could eventually be applied clin-
ically to improve treatment safety. The major findings of the study
can be summarized as follows:
· Standing waves are present in small animal models of FUS
BBBD. Standing waves are not required to induce BBBD.
However, standing waves are a source of variability, causing
unpredicatble pressure fields. Standing waves can be elim-
inated in the skull cavity by using burst comprise of short
pulses at a duty cycle of 50% or less.
· Disruption of the BBB can be achieved at reasonable pressures
and within the recommended clinical dose of microbubbles
using bursts as short as a few microsecond, with delays of up
to a second between bursts. With such short bursts, treatment
times could be greatly reduced by steering the focus through
several target locations within the pulse repetition time. How-
ever, it appears that the use of such short pulses does not nec-
essarily provide a significant improvement in treatment safety.
· Variability in skull bone thickness in rat models has a signifi-
cant impact on insertion loss. For sub-megahertz frequencies,
more accurate in situ pressure estimates can be made by con-
sidering animal mass.
· Microbubble acoustic emissions can be used to actively con-
trol FUS BBBD in real time to ensure treatment safety and
efficacy.
Initial investigation of a clinical scale system which would allow
monitoring of FUS BBBD and passive mapping of the microbubble
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activity shows promise. Continuation of this work will focus on
expanding and testing of the clinical scale system, and continued
development of active treatment control algorithms.
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Error Reduction and Active Control
Focused ultrasound disruption of 
the Blood-Brain barrier is a tech-
nique, close to implementation in 
humans, for localized drug delivery 
in the brain.  In this thesis, sources 
of treatment variability were inves-
tigated, and novel acoustic param-
eters and real-time treatment con-
trol methods were developed.  The 
results highlight the ability of the 
novel methods to improve treatment 
outcome and safety, with potential 
applications in both pre-clinical and 
clinical investigations.
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